WO2021086367A1 - Oral product and method of manufacture - Google Patents
Oral product and method of manufacture Download PDFInfo
- Publication number
- WO2021086367A1 WO2021086367A1 PCT/US2019/059090 US2019059090W WO2021086367A1 WO 2021086367 A1 WO2021086367 A1 WO 2021086367A1 US 2019059090 W US2019059090 W US 2019059090W WO 2021086367 A1 WO2021086367 A1 WO 2021086367A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- mixture
- composition
- aqueous solution
- alginate
- dry mix
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B13/00—Tobacco for pipes, for cigars, e.g. cigar inserts, or for cigarettes; Chewing tobacco; Snuff
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
- A24B15/10—Chemical features of tobacco products or tobacco substitutes
- A24B15/16—Chemical features of tobacco products or tobacco substitutes of tobacco substitutes
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
- A24B15/18—Treatment of tobacco products or tobacco substitutes
- A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
- A24B15/281—Treatment of tobacco products or tobacco substitutes by chemical substances the action of the chemical substances being delayed
- A24B15/283—Treatment of tobacco products or tobacco substitutes by chemical substances the action of the chemical substances being delayed by encapsulation of the chemical substances
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
- A24B15/18—Treatment of tobacco products or tobacco substitutes
- A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
- A24B15/30—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
- A24B15/18—Treatment of tobacco products or tobacco substitutes
- A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
- A24B15/30—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances
- A24B15/302—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances by natural substances obtained from animals or plants
- A24B15/303—Plant extracts other than tobacco
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
- A24B15/18—Treatment of tobacco products or tobacco substitutes
- A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
- A24B15/30—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances
- A24B15/308—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances vitamins
Definitions
- the present disclosure relates to products intended for human consumption.
- the products are configured for oral use and deliver substances such as flavors and/or active ingredients during use.
- Such products may include tobacco or a component derived from tobacco, or may be tobacco-free alternatives.
- Tobacco may be enjoyed in a so-called "smokeless” form.
- smokeless tobacco products are employed by inserting some form of processed tobacco or tobacco-containing formulation into the mouth of the user.
- Conventional formats for such smokeless tobacco products include moist snuff, snus, and chewing tobacco, which are typically formed almost entirely of particulate, granular, or shredded tobacco, and which are either portioned by the user or presented to the user in individual portions, such as in single-use pouches or sachets.
- Other traditional forms of smokeless products include compressed or agglomerated forms, such as plugs, tablets, or pellets.
- Alternative product formats such as tobacco- containing gums and mixtures of tobacco with other plant materials, are also known.
- Smokeless tobacco product configurations that combine tobacco material with various binders and fillers have been proposed more recently, with example product formats including lozenges, pastilles, gels, extruded forms, and the like. See, for example, the types of products described in US Patent App. Pub. Nos.
- the present disclosure generally provides products configured for oral use and methods of making such products.
- the products are intended to impart a taste when used orally, and typically also deliver one or more active ingredients to the consumer, such as nicotine.
- compositions that include a single member from a single classification of components from the list (e.g., a single alginate), or two or more members from a single classification of components from the list (e.g., two sweeteners), or combinations of one or more members from each of two or more classifications of components from the list (e.g., a sweetener and an alginate).
- Embodiment 1 A method of preparing an oral product, comprising: combining a filler and a salt to form a dry mix, the dry mix optionally further including one or more of an alginate, a bleached tobacco, a sweetener, a carbonate salt, and a natural gum; forming an aqueous solution of a flavoring agent or an active ingredient or both a flavoring agent and an active ingredient (meaning the solution may include a single flavoring agent, multiple flavoring agents, a single active ingredient, multiple active ingredients, or both one or more flavoring agents and one or more active ingredients), the solution optionally further including one or more of a pH adjuster, a preservative, a humectant, and a sweetener; adding the aqueous solution to the dry mix to form a mixture; and optionally encasing the mixture within a pouch.
- a pH adjuster a preservative, a humectant, and a sweetener
- Embodiment 2 The method of any preceding embodiment, further comprising forming a second aqueous solution of a sugar alcohol, a pH adjuster, and an optional preservative; and adding the second solution to the mixture prior to encasing the mixture within a pouch.
- Embodiment 3 The method of any preceding embodiment, wherein the dry mix does not include an alginate, further comprising adding an aqueous solution of an alginate and a sugar alcohol to the dry mix.
- Embodiment 4 The method of any preceding embodiment, wherein the dry mix does not include a carbonate salt, further comprising adding an aqueous solution of a carbonate salt to the dry mix.
- Embodiment 5 The method of any preceding embodiment, comprising: combining a filler, an alginate, and a salt to form a dry mix; adding an aqueous solution of a carbonate salt to the dry mix; forming an aqueous solution of both a flavoring agent and an active ingredient (meaning a solution containing one or more flavoring agents and one or more active ingredients), the solution further including a sugar alcohol, a pH adjuster, a preservative, a humectant, and a sweetener; adding the aqueous solution to the dry mix to form a mixture; forming a second aqueous solution of a sugar alcohol, a pH adjuster, a sweetener, and an optional preservative; and adding the second aqueous solution to the mixture to form a second mixture; and optionally encasing the second mixture within a pouch.
- Embodiment 6 The method of any preceding embodiment, comprising: combining a fdler, an alginate, a bleached tobacco, and a salt to form a dry mix; adding an aqueous solution of a carbonate salt to the dry mix; forming an aqueous solution of both a flavoring agent and an active ingredient, the solution further including a sugar alcohol, a pH adjuster, a preservative, and a sweetener; adding the aqueous solution to the dry mix to form a mixture; forming a second aqueous solution of a sugar alcohol, a pH adjuster, a sweetener, and an optional preservative; and adding the second aqueous solution to the mixture to form a second mixture; and optionally encasing the second mixture within a pouch.
- Embodiment 7 The method of any preceding embodiment, comprising: combining a fdler, an alginate, a bleached tobacco, a natural gum, and a salt to form a dry mix; adding an aqueous solution of a carbonate salt to the dry mix; forming an aqueous solution of both a flavoring agent and an active ingredient, the solution further including a sugar alcohol, a pH adjuster, a preservative, and a sweetener; adding the aqueous solution to the dry mix to form a mixture; and optionally encasing the mixture within a pouch.
- Embodiment 8 The method any preceding embodiment, comprising: combining a fdler, a bleached tobacco, a natural gum, a sweetener, a carbonate salt, a preservative, and a salt to form a dry mix; adding an aqueous solution of an alginate and a sugar alcohol to the dry mix to form a mixture; forming a second aqueous solution of both a flavoring agent and an active ingredient; adding the second aqueous solution to the mixture; and optionally encasing the mixture within a pouch.
- Embodiment 9 The method of any preceding embodiment, wherein the temperature of each aqueous solution is between about 30 to about 100°C.
- Embodiment 10 The method of any preceding embodiment, wherein: the fdler is a cellulose material; or the salt is sodium chloride; or the alginate is sodium alginate, calcium alginate, potassium alginate, magnesium alginate, ammonium alginate, or a mixture of two or more of the foregoing; or the sugar alcohol is xylitol; or the pH adjuster is ammonium chloride; or the carbonate salt is sodium bicarbonate; or the active ingredient is selected from the group consisting of a nicotine component, botanicals, stimulants, amino acids, vitamins, and cannabinoids; or the natural gum is guar gum; or the preservative is potassium sorbate; or the sweetener is sucralose or acesulfame K; or a combination of one or more of the above.
- the fdler is a cellulose material
- the salt is sodium chloride
- the alginate is sodium alginate, calcium alginate, potassium alginate, magnesium alginate, ammonium
- Embodiment 11 A method of preparing an oral product, comprising: combining a filler and a salt to form a dry mix, the dry mix optionally further including one or more of an alginate, a bleached tobacco, a sweetener, a carbonate salt, and a natural gum; adding a flavoring agent and an active ingredient to the dry mix to form a mixture, wherein the active ingredient is applied either before, after, or simultaneously with the flavoring agent; thereafter, applying water to the mixture to form a second mixture, wherein at least 50% by weight of the water content of the second mixture is added after adding the active ingredient (such as at least about 55%, 60%, 65%, 70%, 75%, 80%, 85%, or 90%); and optionally encasing the second mixture within a pouch.
- a filler and a salt optionally further including one or more of an alginate, a bleached tobacco, a sweetener, a carbonate salt, and a natural gum
- adding a flavoring agent and an active ingredient to
- Embodiment 12 The method of any preceding embodiment, further comprising introducing one or more capsules into the oral product, the one or more capsules comprising an outer shell and an inner payload, the inner payload comprising at least one flavoring agent, and wherein the one or more capsules optionally include a water-resistant outer coating.
- Embodiment 13 A product configured for oral use, the product prepared by the method of any preceding embodiment.
- Embodiment 14 A method of preparing an oral product containing nicotine, comprising premixing a nicotine component with a humectant to form a premix, thereafter combining the premix with a filler.
- Embodiment 15 The method of any preceding embodiment, wherein the humectant is propylene glycol or olive oil.
- Embodiment 16 A composition, comprising: a filler in an amount of at least 40% percent by weight, based on total weight of the composition (e.g., from about 40% to about 60% by weight of the composition or about 40% to about 50%); a sugar alcohol (e.g., from about 1% to about 10% by weight of the composition or about 2% to about
- a salt e.g., from about 1% to about 10% by weight of the composition or about 2% to about 6%
- an alginate e.g., from about 0.1% to about 10% by weight of the composition or about 0.5% to about 1.5%)
- a sweetener such as an artificial sweetener (e.g., from about 0.1% to about 10% by weight of the composition or about 0.5% to about 1.5%)
- at least one flavoring agent or at least one active ingredient or at least one of both a flavoring agent and an active ingredient e.g., a flavoring agent or active ingredient from about 0.1% to about 10% by weight of the composition or about 0.5% to about 1.5%)
- an optional natural gum e.g., present in an amount of from about 0.1% to about 15% by weight of the composition or about 1% to about 10% or about 2% to about 6%
- a moisture content of at least about 40% by weight e.g., from about 40% to about 60% by weight of the composition or about 40% to about 55%).
- Embodiment 17 The composition of any preceding embodiment, further comprising a humectant (e.g., from about 0.01% to about 10% by weight of the composition or about 0.5% to about 6%).
- a humectant e.g., from about 0.01% to about 10% by weight of the composition or about 0.5% to about 6%.
- Embodiment 18 The composition of any preceding embodiment, wherein the humectant is propylene glycol or olive oil.
- Embodiment 19 The composition of any preceding embodiment, comprising from about 0.001 to about 10% by weight of a nicotine component, calculated as the free base and based on the total weight of the composition (e.g., about 0.5% to about 1.5%).
- Embodiment 20 The composition of any preceding embodiment, wherein the composition is substantially free of tobacco material, excluding any nicotine component present, based on the total weight of the composition.
- Embodiment 21 The composition of any preceding embodiment, wherein: the filler is a cellulose material; or the salt is sodium chloride; or the alginate is sodium alginate, calcium alginate, potassium alginate, magnesium alginate, ammonium alginate, or a mixture of two or more of the foregoing; or the sugar alcohol is xylitol; or the active ingredient is selected from the group consisting of a nicotine component, botanicals, stimulants, amino acids, vitamins, and cannabinoids; or the natural gum is guar gum; or a combination of one or more of the above.
- the filler is a cellulose material
- the salt is sodium chloride
- the alginate is sodium alginate, calcium alginate, potassium alginate, magnesium alginate, ammonium alginate, or a mixture of two or more of the foregoing
- the sugar alcohol is xylitol
- the active ingredient is selected from the group consisting of a nicotine component, botanicals, stimulants, amino acids
- Embodiment 22 The composition of any preceding embodiment, further comprising one or more capsules comprising an outer shell and an inner payload, the inner payload comprising at least one flavoring agent.
- Embodiment 23 The composition of any preceding embodiment, wherein the one or more capsules include a water-resistant outer coating.
- Embodiment 24 The composition of any preceding embodiment, wherein the fdler comprises a cellulose material.
- Embodiment 25 The composition of any preceding embodiment, wherein the cellulose material comprises microcrystalline cellulose.
- Embodiment 26 The composition of any preceding embodiment, comprising from about 10 to about 50% of the one or more particulate filler components; and from about 5 to about 60% by weight of the water, based on the total weight of the composition.
- Embodiment 27 The composition of any preceding embodiment, wherein the composition comprises no more than about 10% by weight of a tobacco material (e.g., from about 0.01% to about 10% by weight of the composition or about 0.5% to about 5%), excluding any nicotine component present, based on the total weight of the composition.
- a tobacco material e.g., from about 0.01% to about 10% by weight of the composition or about 0.5% to about 5%
- Embodiment 28 The composition of any preceding embodiment, wherein the composition is in a free- flowing particulate form.
- Fig. 1 is a cross-sectional view of a pouched product embodiment, taken across the width of the product, showing an outer pouch fdled with a composition of the present disclosure
- Fig. 2 is a bar graph illustrating subjective overall irritation associated with an embodiment of a pouched product of the disclosure.
- Fig. 3 is a schematic view of an active ingredient dosing system according to one embodiment of the present disclosure. DETAILED DESCRIPTION
- the products as described herein comprise a mixture of components, typically including at least one fdler and at least one flavoring agent and/or active ingredient.
- the composition further comprises one or more salts, one or more sweeteners, one or more binding agents, one or more humectants, one or more gums, an organic acid, a tobacco material, a tobacco-derived material, or a combination thereof.
- the relative amounts of the various components within the composition may vary, and typically are selected so as to provide the desired sensory and performance characteristics to the oral product.
- the example individual components of the composition are described herein below.
- Compositions as described herein generally include at least one fdler component.
- fdlers may fulfill multiple functions, such as enhancing certain organoleptic properties such as texture and mouthfeel, enhancing cohesiveness or compressibility of the product, and the like.
- the fdlers are porous particulate materials and are cellulose-based.
- suitable particulate fdlers are any non-tobacco plant material or derivative thereof, including cellulose materials derived from such sources.
- cellulosic non-tobacco plant material examples include cereal grains (e.g., maize, oat, barley, rye, buckwheat, and the like), sugar beet (e.g., FIBREX ® brand fdler available from International Fiber Corporation), bran fiber, and mixtures thereof.
- Non-limiting examples of derivatives of non-tobacco plant material include starches (e.g., from potato, wheat, rice, corn), natural cellulose, and modified cellulosic materials.
- Additional examples of potential particulate fdlers include maltodextrin, dextrose, calcium carbonate, calcium phosphate, lactose, mannitol, xylitol, and sorbitol. Combinations of fdlers can also be used.
- Starch as used herein may refer to pure starch from any source, modified starch, or starch derivatives. Starch is present, typically in granular form, in almost all green plants and in various types of plant tissues and organs (e.g., seeds, leaves, rhizomes, roots, tubers, shoots, fruits, grains, and stems). Starch can vary in composition, as well as in granular shape and size. Often, starch from different sources has different chemical and physical characteristics. A specific starch can be selected for inclusion in the composition based on the ability of the starch material to impart a specific organoleptic property to composition. Starches derived from various sources can be used.
- starch major sources include cereal grains (e.g., rice, wheat, and maize) and root vegetables (e.g., potatoes and cassava).
- sources of starch include acorns, arrowroot, arracacha, bananas, barley, beans (e.g., favas, lentils, mung beans, peas, chickpeas), breadfruit, buckwheat, canna, chestnuts, colacasia, katakuri, kudzu, malanga, millet, oats, oca, Polynesian arrowroot, sago, sorghum, sweet potato, quinoa, rye, tapioca, taro, tobacco, water chestnuts, and yams.
- modified starches are modified starches.
- a modified starch has undergone one or more structural modifications, often designed to alter its high heat properties. Some starches have been developed by genetic modifications, and are considered to be "modified” starches. Other starches are obtained and subsequently modified.
- modified starches can be starches that have been subjected to chemical reactions, such as esterification, etherification, oxidation, depolymerization (thinning) by acid catalysis or oxidation in the presence of base, bleaching, transglycosylation and depolymerization (e.g., dextrinization in the presence of a catalyst), cross-linking, enzyme treatment, acetylation, hydroxypropylation, and/or partial hydrolysis.
- modified starches are modified by heat treatments, such as pregelatinization, dextrinization, and/or cold water swelling processes.
- Certain modified starches include monostarch phosphate, distarch glycerol, distarch phosphate esterified with sodium trimetaphosphate, phosphate distarch phosphate, acetylated distarch phosphate, starch acetate esterified with acetic anhydride, starch acetate esterified with vinyl acetate, acetylated distarch adipate, acetylated distarch glycerol, hydroxypropyl starch, hydroxypropyl distarch glycerol, starch sodium octenyl succinate.
- the particulate filler is a cellulose material or cellulose derivative.
- One particularly suitable particulate filler for use in the products described herein is microcry stalline cellulose ("mcc").
- the mcc may be synthetic or semi-synthetic, or it may be obtained entirely from natural celluloses.
- the mcc may be selected from the group consisting of AVICEL ® grades PH-100, PH-102, PH-103, PH-105, PH-112, PH-113, PH-200, PH-300, PH-302, VIVACEL ® grades 101, 102, 12, 20 and EMOCEL ® grades 50M and 90M, and the like, and mixtures thereof.
- the composition comprises mcc as the particulate fdler component.
- the quantity of mcc present in the composition as described herein may vary according to the desired properties.
- the amount of filler can vary, but is typically up to about 75 percent of the composition by weight, based on the total weight of the composition.
- a typical range of particulate fdler (e.g., mcc) within the composition can be from about 10 to about 75 percent by total weight of the composition, for example, from about 10, about 15, about 20, about 25, or about 30, to about 35, about 40, about 45, or about 50 weight percent (e.g., about 20 to about 50 weight percent or about 25 to about 45 weight percent).
- the amount of particulate filler material is at least about 10 percent by weight, such as at least about 20 percent, or at least about 25 percent, or at least about 30 percent, or at least about 35 percent, or at least about 40 percent, based on the total weight of the composition.
- the particulate filler further comprises a cellulose derivative or a combination of such derivatives.
- the composition comprises from about 1 to about 10% of the cellulose derivative by weight, based on the total weight of the composition, with certain embodiments comprising about 1 to about 5% by weight of cellulose derivative.
- the cellulose derivative is a cellulose ether (including carboxyalkyl ethers), meaning a cellulose polymer with the hydrogen of one or more hydroxyl groups in the cellulose structure replaced with an alkyl, hydroxyalkyl, or aryl group.
- cellulose derivatives include methylcellulose, hydroxypropylcellulose ("HPC"), hydroxypropylmethylcellulose ("HPMC”), hydroxyethyl cellulose, and carboxymethylcellulose ("CMC”).
- the cellulose derivative is one or more of methylcellulose, HPC, HPMC, hydroxyethyl cellulose, and CMC.
- the cellulose derivative is HPC.
- the composition comprises from about 1 to about 3% HPC by weight, based on the total weight of the composition.
- the water content of the composition, prior to use by a consumer of the product, may vary according to the desired properties.
- the composition, as present within the product prior to insertion into the mouth of the user is less than about 60 percent by weight of water, and generally is from about 1 to about 60% by weight of water, for example, from about 5 to about 55, about 10 to about 50, about 20 to about 45, or about 25 to about 40 percent water by weight, including water amounts of at least about 5% by weight, at least about 10% by weight, at least about 15% by weight, and at least about 20% by weight.
- organic acid refers to an organic (i.e., carbon-based) compound that is characterized by acidic properties.
- organic acids are relatively weak acids (i.e., they do not dissociate completely in the presence of water), such as carboxylic acids (-CO2H) or sulfonic acids (- SO2OH).
- reference to organic acid means an organic acid that is intentionally added.
- an organic acid may be intentionally added as a specific composition ingredient as opposed to merely being inherently present as a component of another composition ingredient (e.g., the small amount of organic acid which may inherently be present in a composition ingredient such as a tobacco material).
- the one or more organic acids are added neat (i.e., in their free acid, native solid or liquid form) or as a solution in, e.g., water. In some embodiments, the one or more organic acids are added in the form of a salt, as described herein below.
- the organic acid is an alkyl carboxylic acid.
- alkyl carboxylic acids include formic acid, acetic acid, propionic acid, octanoic acid, nonanoic acid, decanoic acid, undecanoic acid, dodecanoic acid, stearic acid, oleic acid, linoleic acid, linolenic acid, and the like.
- the organic acid is an alkyl sulfonic acid.
- alkyl sulfonic acids include propanesulfonic acid and octanesulfonic acid.
- the organic acid is citric acid, malic acid, tartaric acid, octanoic acid, benzoic acid, a toluic acid, salicylic acid, or a combination thereof. In some embodiments, the organic acid is benzoic acid. In some embodiments, the organic acid is citric acid.
- a portion, or even all, of the organic acid may be added in the form of a salt with an alkaline component, which may include, but is not limited to, nicotine.
- suitable salts e.g., for nicotine, include formate, acetate, propionate, isobutyrate, butyrate, alpha- methylbutyate, isovalerate, beta-methylvalerate, caproate, 2-furoate, phenylacetate, heptanoate, octanoate, nonanoate, oxalate, malonate, glycolate, benzoate, tartrate, levulinate, ascorbate, fumarate, citrate, malate, lactate, aspartate, salicylate, tosylate, succinate, pyruvate, and the like.
- the organic acid or a portion thereof may be added in the form of a salt with an alkali metal such as sodium, potassium, and the like.
- organic acids having more than one acidic group such as a di- or-tri-carboxylic acid
- one or more of these acid groups may be in the form of such a salt.
- Suitable non-limiting examples include monosodium citrate, disodium citrate, and the like.
- the organic acid is a salt of citric acid, malic acid, tartaric acid, octanoic acid, benzoic acid, a toluic acid, salicylic acid, or a combination thereof.
- the organic acid is a mono or di-ester of a di- or tri-carboxylic acid, respectively, such as a monomethyl ester of citric acid, malic acid, or tartaric acid, or a dimethyl ester of citric acid.
- the amount of organic acid present in the composition may vary. Generally, the composition comprises from about 0.1 to about 10% by weight of organic acid, present as one or more organic acids, based on the total weight of the composition. In some embodiments, the composition comprises about 0.1%, about 0.2%, about 0.3%, about 0.4%, about 0.5%, about 0.6%, about 0.7%, about 0.8%, about 0.9%, about 1%, about 2%, about 3%, about 4%, about 5%, about 6%, about 7%, about 8%, about 9%, or about 10% organic acid by weight, based on the total weight of the composition.
- the composition comprises from about 0.1 to about 0.5% by weight of organic acid, for example, about 0.1, about 0.15, about 0.2, about 0.25, about 0.3, about 0.35, about 0.4, about 0.45, or about 0.5% by weight, based on the total weight of the composition.
- the composition comprises from about 0.25 to about 0.35% by weight of organic acid, for example, from about 0.25, about 0.26, about 0.27, about 0.28, about 0.29, or about 0.3, to about 0.31, about 0.32, about 0.33, about 0.34, or about 0.35% by weight, based on the total weight of the composition.
- the percent by weight is calculated based on the weight of the free acid, not including any counter-ion which may be present.
- the quantity of acid present will vary based on the acidity and basicity of other components which may be present in the composition (e.g., nicotine, salts, buffers, and the like). Accordingly, the organic acid is provided in a quantity sufficient to provide a pH of 7.0 or below, (typically about 6.8 or below, about 6.6 or below, or about 6.5 or below) of the composition. In certain embodiments the acid inclusion is sufficient to provide a composition pH of from about 4.0 to about 7.0; for example, from about 4.5, about 5.0, about
- the organic acid is provided in a quantity sufficient to provide a pH of the composition of from about 5.5 to about 6.5, for example, from about 5.5, about 5.6, about 5.7, about 5.8, about 5.9, or about 6.0, to about 6.1, about 6.2, about 6.3, about 6.4, or about
- flavoring agent or “flavorant” is any flavorful or aromatic substance capable of altering the sensory characteristics associated with the oral product.
- sensory characteristics that can be modified by the flavoring agent include taste, mouthfeel, moistness, coolness/heat, and/or fragrance/aroma.
- Flavoring agents may be natural or synthetic, and the character of the flavors imparted thereby may be described, without limitation, as fresh, sweet, herbal, confectionary, floral, fruity, or spicy.
- flavors include, but are not limited to, vanilla, coffee, chocolate/cocoa, cream, mint, spearmint, menthol, peppermint, wintergreen, eucalyptus, lavender, cardamon, nutmeg, cinnamon, clove, cascarilla, sandalwood, honey, jasmine, ginger, anise, sage, licorice, lemon, orange, apple, peach, lime, cherry, strawberry, and any combinations thereof. See also, Leffmgwell et al., Tobacco Flavoring for Smoking Products, R. J. Reynolds Tobacco Company (1972), which is incorporated herein by reference. Flavorings also may include components that are considered moistening, cooling or smoothening agents, such as eucalyptus.
- flavors may be provided neat (i.e., alone) or in a composite, and may be employed as concentrates or flavor packages (e.g., spearmint and menthol, orange and cinnamon; lime, pineapple, and the like).
- Representative types of components also are set forth in US Pat. No. 5,387,416 to White et al.; US Pat. App. Pub. No. 2005/0244521 to Strickland et al.; and PCT Application Pub. No. WO 05/041699 to Quinter et al., each of which is incorporated herein by reference.
- the flavoring agent may be provided in a spray-dried form or a liquid form.
- the flavoring agent generally comprises at least one volatile flavor component.
- volatile refers to a chemical substance that forms a vapor readily at ambient temperatures (i.e., a chemical substance that has a high vapor pressure at a given temperature relative to a nonvolatile substance).
- a volatile flavor component has a molecular weight below about 400 Da, and often include at least one carbon-carbon double bond, carbon-oxygen double bond, or both.
- the at least one volatile flavor component comprises one or more alcohols, aldehydes, aromatic hydrocarbons, ketones, esters, terpenes, terpenoids, or a combination thereof.
- Non-limiting examples of aldehydes include vanillin, ethyl vanillin, p-anisaldehyde, hexanal, furfural, isovaleraldehyde, cuminaldehyde, benzaldehyde, and citronellal.
- Non-limiting examples of ketones include l-hydroxy-2-propanone and 2-hydroxy-3-methyl-2- cyclopentenone-l-one.
- Non-limiting examples of esters include allyl hexanoate, ethyl heptanoate, ethyl hexanoate, isoamyl acetate, and 3-methylbutyl acetate.
- Non-limiting examples of terpenes include sabinene, limonene, gamma-terpinene, beta-fame sene, nerolidol, thujone, myrcene, geraniol, nerol, citronellol, linalool, and eucalyptol.
- the at least one volatile flavor component comprises one or more of ethyl vanillin, cinnamaldehyde, sabinene, limonene, gamma-terpinene, beta-farnesene, or citral.
- the at least one volatile flavor component comprises ethyl vanillin.
- the amount of flavoring agent utilized in the composition can vary, but is typically up to about 10 weight percent, and certain embodiments are characterized by a flavoring agent content of at least about 0.1 weight percent, such as about 0.5 to about 10 weight percent, about 1 to about 6 weight percent, or about 2 to about 5 weight percent, based on the total weight of the composition.
- the composition may further comprise a salt (e.g., alkali metal salts), typically employed in an amount sufficient to provide desired sensory attributes to the composition.
- a salt e.g., alkali metal salts
- suitable salts include sodium chloride, potassium chloride, ammonium chloride, flour salt, and the like.
- a representative amount of salt is about 0.5 percent by weight or more, about 1.0 percent by weight or more, or at about 1.5 percent by weight or more, but will typically make up about 10 percent or less of the total weight of the composition, or about 7.5 percent or less or about 5 percent or less (e.g., about 0.5 to about 5 percent by weight).
- the composition typically further comprises one or more sweeteners.
- the sweeteners can be any sweetener or combination of sweeteners, in natural or artificial form, or as a combination of natural and artificial sweeteners.
- natural sweeteners include fructose, sucrose, glucose, maltose, mannose, galactose, lactose, stevia, honey, and the like.
- artificial sweeteners include sucralose, isomaltulose, maltodextrin, saccharin, aspartame, acesulfame K, neotame and the like.
- the sweetener comprises one or more sugar alcohols.
- Sugar alcohols are polyols derived from monosaccharides or disaccharides that have a partially or fully hydrogenated form.
- Sugar alcohols have, for example, about 4 to about 20 carbon atoms and include erythritol, arabitol, ribitol, isomalt, maltitol, dulcitol, iditol, mannitol, xylitol, lactitol, sorbitol, and combinations thereof (e.g., hydrogenated starch hydrolysates).
- a representative amount of sweetener may make up from about 0.1 to about 20 percent or more of the of the composition by weight, for example, from about 0.1 to about 1%, from about 1 to about 5%, from about 5 to about 10%, or from about 10 to about 20% of the composition on a weight basis, based on the total weight of the composition.
- a binder (or combination of binders) may be employed in certain embodiments, in amounts sufficient to provide the desired physical attributes and physical integrity to the composition.
- Typical binders can be organic or inorganic, or a combination thereof.
- Representative binders include povidone, sodium alginate, starch-based binders, pectin, carrageenan, pullulan, zein, and the like, and combinations thereof.
- a binder may be employed in amounts sufficient to provide the desired physical attributes and physical integrity to the composition.
- the amount of binder utilized in the composition can vary, but is typically up to about 30 weight percent, and certain embodiments are characterized by a binder content of at least about 0.1% by weight, such as about 1 to about 30% by weight, or about 5 to about 10% by weight, based on the total weight of the composition.
- the binder includes a gum, for example, a natural gum.
- a natural gum refers to polysaccharide materials of natural origin that have binding properties, and which are also useful as a thickening or gelling agents.
- Representative natural gums derived from plants, which are typically water soluble to some degree, include xanthan gum, guar gum, gum arabic, ghatti gum, gum tragacanth, karaya gum, locust bean gum, gellan gum, and combinations thereof.
- natural gum binder materials are typically present in an amount of up to about 5% by weight, for example, from about 0.1, about 0.2, about 0.3, about 0.4, about 0.5, about 0.6, about 0.7, about 0.8, about 0.9, or about 1%, to about 2, about 3, about 4, or about 5% by weight, based on the total weight of the composition.
- one or more humectants may be employed in the composition.
- humectants include, but are not limited to, glycerin, propylene glycol, and the like.
- plant-based oils such as olive oil, almond oil, avocado seed oil, coconut oil, corn oil, cottonseed oil, flax seed oil, grapeseed oil, hemp oil, palm kernel oil, peanut oil, pumpkin seed oil, rice bran oil, safflower seed oil, sesame seed oil, sunflower seed oil, soybean oil, or walnut oil.
- the humectant is typically provided in an amount sufficient to provide desired moisture attributes to the composition. Further, in some instances, the humectant may impart desirable flow characteristics to the composition for depositing in a mold.
- a humectant When present, a humectant will typically make up about 5% or less of the weight of the composition (e.g., from about 0.5 to about 5% by weight). When present, a representative amount of humectant is about 0.1% to about 1% by weight, or about 1% to about 5% by weight, based on the total weight of the composition.
- the composition of the present disclosure can comprise pH adjusters or buffering agents.
- pH adjusters and buffering agents include, but are not limited to, metal hydroxides (e.g., alkali metal hydroxides such as sodium hydroxide and potassium hydroxide), and other alkali metal buffers such as metal carbonates (e.g., potassium carbonate or sodium carbonate), or metal bicarbonates such as sodium bicarbonate, and the like.
- the buffering agent is typically present in an amount less than about 5 percent based on the weight of the composition, for example, from about 0.5% to about 5%, such as, e.g., from about 0.75% to about 4%, from about 0.75% to about 3%, or about 0.5% to about 1.5%, or from about 1% to about 2% by weight, based on the total weight of the composition.
- suitable buffers include alkali metals acetates, glycinates, phosphates, glycerophosphates, citrates, carbonates, hydrogen carbonates, borates, or mixtures thereof.
- a colorant may be employed in amounts sufficient to provide the desired physical attributes to the composition.
- colorants include various dyes and pigments, such as caramel coloring and titanium dioxide.
- the amount of colorant utilized in the composition can vary, but when present is typically up to about 3 weight percent, such as from about 0.1%, about 0.5%, or about 1%, to about 3% by weight, based on the total weight of the composition.
- the composition may additionally include one or more active ingredients including, but not limited to, a nicotine component, botanical ingredients (e.g., lavender, peppermint, chamomile, basil, rosemary, ginger, cannabis, ginseng, maca, and tisanes), stimulants (e.g., caffeine and guarana), amino acids (e.g., taurine, theanine, phenylalanine, tyrosine, and tryptophan) and/or pharmaceutical, nutraceutical, and medicinal ingredients (e.g., vitamins, such as B6, B12, and C, and/or cannabinoids, such as tetrahydrocannabinol (THC) and cannabidiol (CBD)).
- active ingredients including, but not limited to, a nicotine component, botanical ingredients (e.g., lavender, peppermint, chamomile, basil, rosemary, ginger, cannabis, ginseng, maca, and tisanes), stimulants (e.g., caffeine and guarana
- Example active ingredients would include any ingredient known to impact one or more biological functions within the body, such as ingredients that furnish pharmacological activity or other direct effect in the diagnosis, cure, mitigation, treatment, or prevention of disease, or which affect the structure or any function of the body of humans or other animals (e.g., provide a stimulating action on the central nervous system, have an energizing effect, an antipyretic or analgesic action, or an otherwise useful effect on the body).
- a nicotine component may be included in the composition.
- nicotine component is meant any suitable form of nicotine (e.g., free base or salt) for providing oral absorption of at least a portion of the nicotine present.
- the nicotine component is selected from the group consisting of nicotine free base and a nicotine salt.
- nicotine is in its free base form, which easily can be adsorbed in for example, a microcrystalline cellulose material to form a microcrystalline cellulose-nicotine carrier complex. See, for example, the discussion of nicotine in free base form in US Pat. Pub. No. 2004/0191322 to Hansson, which is incorporated herein by reference.
- the nicotine can be employed in the form of a salt.
- Salts of nicotine can be provided using the types of ingredients and techniques set forth in US Pat. No. 2,033,909 to Cox et al. and Perfetti, Beitrage Tabak Kauutz. Int., 12: 43-54 (1983), which are incorporated herein by reference. Additionally, salts of nicotine are available from sources such as Pfaltz and Bauer, Inc. and K&K Laboratories, Division of ICN Biochemicals, Inc.
- the nicotine component is selected from the group consisting of nicotine free base, a nicotine salt such as hydrochloride, dihydrochloride, monotartrate, bitartrate, sulfate, salicylate, and nicotine zinc chloride.
- the nicotine component or a protion thereof is a nicotine salt with at least a portion of the one or more organic acids as disclosed herein above.
- the nicotine can be in the form of a resin complex of nicotine, where nicotine is bound in an ion-exchange resin, such as nicotine polacrilex, which is nicotine bound to, for example, a polymethacrilic acid, such as Amberlite IRP64, Purolite C115HMR, or Doshion P551.
- an ion-exchange resin such as nicotine polacrilex
- a polymethacrilic acid such as Amberlite IRP64, Purolite C115HMR, or Doshion P551.
- a nicotine-polyacrylic carbomer complex such as with Carbopol 974P.
- nicotine may be present in the form of a nicotine polyacrylic complex.
- the nicotine component when present, is in a concentration of at least about 0.001% by weight of the composition, such as in a range from about 0.001% to about 10%.
- the nicotine component is present in a concentration from about 0.1% w/w to about 10% by weight, such as, e.g., from about from about 0.1% w/w, about 0.2%, about 0.3%, about 0.4%, about 0.5% about 0.6%, about 0.7%, about 0.8%, or about 0.9%, to about 1%, about 2%, about 3%, about 4%, about 5%, about 6%, about 7%, about 8%, about 9%, or about 10% by weight, calculated as the free base and based on the total weight of the composition.
- the nicotine component is present in a concentration from about 0.1% w/w to about 3% by weight, such as, e.g., from about from about 0.1% w/w to about 2.5%, from about 0.1% to about 2.0%, from about 0.1% to about 1.5%, or from about 0.1% to about 1% by weight, calculated as the free base and based on the total weight of the composition.
- concentration from about 0.1% w/w to about 3% by weight, such as, e.g., from about from about 0.1% w/w to about 2.5%, from about 0.1% to about 2.0%, from about 0.1% to about 1.5%, or from about 0.1% to about 1% by weight, calculated as the free base and based on the total weight of the composition.
- the composition may include a tobacco material.
- the tobacco material can vary in species, type, and form. Generally, the tobacco material is obtained from for a harvested plant of the Nicotiana species.
- Example Nicotiana species include N. tabacum, N. rustica, N. alata, N. arentsii, N. excelsior, N. forgetiana, N. glauca, N. glutinosa, N. gossei, N. kawakamii, N. knightiana, N. langsdorffi, N. otophora, N. setchelli, N. sylvestris, N. tomentosa, N. tomentosiformis, N. undulata, N.
- Nicotiana species from which suitable tobacco materials can be obtained can be derived using genetic-modification or crossbreeding techniques (e.g., tobacco plants can be genetically engineered or crossbred to increase or decrease production of components, characteristics or attributes). See, for example, the types of genetic modifications of plants set forth in US Pat. Nos. 5,539,093 to Fitzmaurice et al.; 5,668,295 to Wahab et al.; 5,705,624 to Fitzmaurice et al.; 5,844,119 to Weigl; 6,730,832 to Dominguez et al.; 7,173,170 to Liu et al.; 7,208,659 to Colliver et al.
- the Nicotiana species can, in some embodiments, be selected for the content of various compounds that are present therein. For example, plants can be selected on the basis that those plants produce relatively high quantities of one or more of the compounds desired to be isolated therefrom.
- plants of the Nicotiana species e.g., Galpao commun tobacco
- the plant of the Nicotiana species can be included within a composition as disclosed herein.
- virtually all of the plant ⁇ e.g., the whole plant
- various parts or pieces of the plant can be harvested or separated for further use after harvest.
- the flower, leaves, stem, stalk, roots, seeds, and various combinations thereof, can be isolated for further use or treatment.
- the tobacco material comprises tobacco leaf (lamina).
- composition disclosed herein can include processed tobacco parts or pieces, cured and aged tobacco in essentially natural lamina and/or stem form, a tobacco extract, extracted tobacco pulp (e.g., using water as a solvent), or a mixture of the foregoing (e.g., a mixture that combines extracted tobacco pulp with granulated cured and aged natural tobacco lamina).
- the tobacco material comprises solid tobacco material selected from the group consisting of lamina and stems.
- the tobacco that is used for the composition most preferably includes tobacco lamina, or a tobacco lamina and stem mixture (of which at least a portion is smoke-treated).
- Portions of the tobaccos within the composition may have processed forms, such as processed tobacco stems (e.g., cut-rolled stems, cut-rolled-expanded stems or cut-puffed stems), or volume expanded tobacco (e.g., puffed tobacco, such as dry ice expanded tobacco (DIET)). See, for example, the tobacco expansion processes set forth in US Pat. Nos.
- the d composition optionally may incorporate tobacco that has been fermented. See, also, the types of tobacco processing techniques set forth in PCT W02005/063060 to Atchley et al., which is incorporated herein by reference.
- the tobacco material is typically used in a form that can be described as particulate (i.e., shredded, ground, granulated, or powder form).
- the manner by which the tobacco material is provided in a finely divided or powder type of form may vary.
- plant parts or pieces are comminuted, ground or pulverized into a particulate form using equipment and techniques for grinding, milling, or the like.
- the plant material is relatively dry in form during grinding or milling, using equipment such as hammer mills, cutter heads, air control mills, or the like.
- tobacco parts or pieces may be ground or milled when the moisture content thereof is less than about 15 weight percent or less than about 5 weight percent.
- the tobacco material is employed in the form of parts or pieces that have an average particle size between 1.4 millimeters and 250 microns.
- the tobacco particles may be sized to pass through a screen mesh to obtain the particle size range required.
- air classification equipment may be used to ensure that small sized tobacco particles of the desired sizes, or range of sizes, may be collected.
- differently sized pieces of granulated tobacco may be mixed together.
- tobacco parts or pieces are comminuted, ground or pulverized into a powder type of form using equipment and techniques for grinding, milling, or the like.
- the tobacco is relatively dry in form during grinding or milling, using equipment such as hammer mills, cutter heads, air control mills, or the like.
- tobacco parts or pieces may be ground or milled when the moisture content thereof is less than about 15 weight percent to less than about 5 weight percent.
- the tobacco plant or portion thereof can be separated into individual parts or pieces (e.g., the leaves can be removed from the stems, and/or the stems and leaves can be removed from the stalk).
- the harvested plant or individual parts or pieces can be further subdivided into parts or pieces (e.g., the leaves can be shredded, cut, comminuted, pulverized, milled or ground into pieces or parts that can be characterized as filler-type pieces, granules, particulates or fine powders).
- the plant, or parts thereof can be subjected to external forces or pressure (e.g., by being pressed or subjected to roll treatment).
- the plant or portion thereof can have a moisture content that approximates its natural moisture content (e.g., its moisture content immediately upon harvest), a moisture content achieved by adding moisture to the plant or portion thereof, or a moisture content that results from the drying of the plant or portion thereof.
- powdered, pulverized, ground or milled pieces of plants or portions thereof can have moisture contents of less than about 25 weight percent, often less than about 20 weight percent, and frequently less than about 15 weight percent.
- a harvested plant of the Nicotiana species it is typical for a harvested plant of the Nicotiana species to be subjected to a curing process.
- the tobacco materials incorporated within the composition for inclusion within products as disclosed herein are those that have been appropriately cured and/or aged. Descriptions of various types of curing processes for various types of tobaccos are set forth in Tobacco Production, Chemistry and Technology, Davis et al. (Eds.) (1999). Examples of techniques and conditions for curing flue-cured tobacco are set forth in Nestor et al., Beitrage Tabakforsch.
- tobacco materials that can be employed include flue-cured or Virginia (e.g., K326), hurley, sun-cured (e.g., Indian Kumool and Oriental tobaccos, including Katerini, Prelip, Komotini, Xanthi and Yambol tobaccos), Maryland, dark, dark-fired, dark air cured (e.g., Madole, Passanda, Cubano, Jatin and Bezuki tobaccos), light air cured (e.g., North Wisconsin and Galpao tobaccos), Indian air cured, Red Russian and Rustica tobaccos, as well as various other rare or specialty tobaccos and various blends of any of the foregoing tobaccos.
- flue-cured or Virginia e.g., K326)
- hurley sun-cured
- Indian Kumool and Oriental tobaccos including Katerini, Prelip, Komotini, Xanthi and Yambol tobaccos
- Maryland dark, dark-fired, dark air cured (e.g., Madole,
- the tobacco material may also have a so-called "blended" form.
- the tobacco material may include a mixture of parts or pieces of flue-cured, hurley (e.g., Malawi hurley tobacco) and Oriental tobaccos (e.g., as tobacco composed of, or derived from, tobacco lamina, or a mixture of tobacco lamina and tobacco stem).
- a representative blend may incorporate about 30 to about 70 parts hurley tobacco (e.g., lamina, or lamina and stem), and about 30 to about 70 parts flue cured tobacco (e.g., stem, lamina, or lamina and stem) on a dry weight basis.
- example tobacco blends incorporate about 75 parts flue-cured tobacco, about 15 parts hurley tobacco, and about 10 parts Oriental tobacco; or about 65 parts flue-cured tobacco, about 25 parts hurley tobacco, and about 10 parts Oriental tobacco; or about 65 parts flue-cured tobacco, about 10 parts hurley tobacco, and about 25 parts Oriental tobacco; on a dry weight basis.
- Other example tobacco blends incorporate about 20 to about 30 parts Oriental tobacco and about 70 to about 80 parts flue-cured tobacco on a dry weight basis.
- Tobacco materials used in the present disclosure can be subjected to, for example, fermentation, bleaching, and the like.
- the tobacco materials can be, for example, irradiated, pasteurized, or otherwise subjected to controlled heat treatment.
- controlled heat treatment processes are detailed, for example, in US Pat. No. 8,061,362 to Mua et al., which is incorporated herein by reference.
- tobacco materials can be treated with water and an additive capable of inhibiting reaction of asparagine to form acrylamide upon heating of the tobacco material (e.g., an additive selected from the group consisting of lysine, glycine, histidine, alanine, methionine, cysteine, glutamic acid, aspartic acid, proline, phenylalanine, valine, arginine, compositions incorporating di- and trivalent cations, asparaginase, certain non-reducing saccharides, certain reducing agents, phenolic compounds, certain compounds having at least one free thiol group or functionality, oxidizing agents, oxidation catalysts, natural plant extracts (e.g., rosemary extract), and combinations thereof.
- an additive selected from the group consisting of lysine, glycine, histidine, alanine, methionine, cysteine, glutamic acid, aspartic acid, proline, phenylalanine, valine, arginine, compositions incorporating di
- the type of tobacco material is selected such that it is initially visually lighter in color than other tobacco materials to some degree (e.g., whitened or bleached).
- Tobacco pulp can be whitened in certain embodiments according to any means known in the art.
- bleached tobacco material produced by various whitening methods using various bleaching or oxidizing agents and oxidation catalysts can be used.
- Example oxidizing agents include peroxides (e.g., hydrogen peroxide), chlorite salts, chlorate salts, perchlorate salts, hypochlorite salts, ozone, ammonia, potassium permanganate, and combinations thereof.
- Example oxidation catalysts are titanium dioxide, manganese dioxide, and combinations thereof.
- the whitened tobacco material can have an ISO brightness of at least about 50%, at least about 60%, at least about 65%, at least about 70%, at least about 75%, or at least about 80%. In some embodiments, the whitened tobacco material can have an ISO brightness in the range of about 50% to about 90%, about 55% to about 75%, or about 60% to about 70%. ISO brightness can be measured according to ISO 3688:1999 or ISO 2470-1:2016.
- the whitened tobacco material can be characterized as lightened in color (e.g., "whitened") in comparison to an untreated tobacco material.
- White colors are often defined with reference to the International Commission on Illumination's (CIE's) chromaticity diagram.
- CIE's International Commission on Illumination's
- the whitened tobacco material can, in certain embodiments, be characterized as closer on the chromaticity diagram to pure white than an untreated tobacco material.
- the tobacco material can be treated to extract a soluble component of the tobacco material therefrom.
- tobacco extract refers to the isolated components of a tobacco material that are extracted from solid tobacco pulp by a solvent that is brought into contact with the tobacco material in an extraction process.
- Typical inclusion ranges for tobacco materials can vary depending on the nature and type of the tobacco material, and the intended effect on the final composition, with an example range of up to about 30% by weight (or up to about 20% by weight or up to about 10% by weight or up to about 5% by weight), based on total weight of the composition (e.g., about 0.1 to about 15% by weight).
- the products of the disclosure can be characterized as completely free or substantially free of tobacco material (other than purified nicotine as an active ingredient).
- certain embodiments can be characterized as having less than 1% by weight, or less than 0.5% by weight, or less than 0.1% by weight of tobacco material, or 0% by weight of tobacco material.
- additives can be included in the disclosed composition.
- the composition can be processed, blended, formulated, combined and/or mixed with other materials or ingredients.
- the additives can be artificial, or can be obtained or derived from herbal or biological sources.
- further types of additives include thickening or gelling agents (e.g., fish gelatin), emulsifiers, oral care additives (e.g., thyme oil, eucalyptus oil, and zinc), preservatives (e.g., potassium sorbate and the like), disintegration aids, or combinations thereof. See, for example, those representative components, combination of components, relative amounts of those components, and manners and methods for employing those components, set forth in US Pat. No.
- additives can be employed together (e.g., as additive formulations) or separately (e.g., individual additive components can be added at different stages involved in the preparation of the final composition).
- aforementioned types of additives may be encapsulated as provided in the final product or composition. Exemplary encapsulated additives are described, for example, in WO2010/132444 to Atchley, which has been previously incorporated by reference herein.
- any one or more of a filler, a tobacco material, and the overall oral product described herein can be described as a particulate material.
- the term "particulate” refers to a material in the form of a plurality of individual particles, some of which can be in the form of an agglomerate of multiple particles, wherein the particles have an average length to width ratio less than 2:1, such as less than 1.5:1, such as about 1:1.
- the particles of a particulate material can be described as substantially spherical or granular.
- the particle size of a particulate material may be measured by sieve analysis.
- sieve analysis is a method used to measure the particle size distribution of a particulate material.
- sieve analysis involves a nested column of sieves which comprise screens, preferably in the form of wire mesh cloths. A pre-weighed sample may be introduced into the top or uppermost sieve in the column, which has the largest screen openings or mesh size (i.e. the largest pore diameter of the sieve). Each lower sieve in the column has progressively smaller screen openings or mesh sizes than the sieve above.
- a receiver portion to collect any particles having a particle size smaller than the screen opening size or mesh size of the bottom or lowermost sieve in the column (which has the smallest screen opening or mesh size).
- the column of sieves may be placed on or in a mechanical agitator.
- the agitator causes the vibration of each of the sieves in the column.
- the mechanical agitator may be activated for a pre-determined period of time in order to ensure that all particles are collected in the correct sieve.
- the column of sieves is agitated for a period of time from 0.5 minutes to 10 minutes, such as from 1 minute to 10 minutes, such as from 1 minute to 5 minutes, such as for approximately 3 minutes.
- the screen opening sizes or mesh sizes for each sieve in the column used for sieve analysis may be selected based on the granularity or known maximum/minimum particle sizes of the sample to be analysed.
- a column of sieves may be used for sieve analysis, wherein the column comprises from 2 to 20 sieves, such as from 5 to 15 sieves.
- a column of sieves may be used for sieve analysis, wherein the column comprises 10 sieves.
- the largest screen opening or mesh sizes of the sieves used for sieve analysis may be 1000 pm, such as 500 pm, such as 400 pm, such as 300 pm.
- any particulate material referenced herein can be characterized as having at least 50% by weight of particles with a particle size as measured by sieve analysis of no greater than about 1000 pm, such as no greater than about 500 pm, such as no greater than about 400 pm, such as no greater than about 350 pm, such as no greater than about 300 pm.
- at least 60% by weight of the particles of any particulate material referenced herein have a particle size as measured by sieve analysis of no greater than about 1000 pm, such as no greater than about 500 pm, such as no greater than about 400 pm, such as no greater than about 350 pm, such as no greater than about 300 pm.
- At least 70% by weight of the particles of any particulate material referenced herein have a particle size as measured by sieve analysis of no greater than about 1000 pm, such as no greater than about 500 pm, such as no greater than about 400 pm, such as no greater than about 350 pm, such as no greater than about 300 pm. In some embodiments, at least 80% by weight of the particles of any particulate material referenced herein have a particle size as measured by sieve analysis of no greater than about 1000 pm, such as no greater than about 500 pm, such as no greater than about 400 pm, such as no greater than about 350 pm, such as no greater than about 300 pm.
- At least 90% by weight of the particles of any particulate material referenced herein have a particle size as measured by sieve analysis of no greater than about 1000 pm, such as no greater than about 500 pm, such as no greater than about 400 pm, such as no greater than about 350 pm, such as no greater than about 300 pm. In some embodiments, at least 95% by weight of the particles of any particulate material referenced herein have a particle size as measured by sieve analysis of no greater than about 1000 pm, such as no greater than about 500 pm, such as no greater than about 400 pm, such as no greater than about 350 pm, such as no greater than about 300 pm.
- At least 99% by weight of the particles of any particulate material referenced herein have a particle size as measured by sieve analysis of no greater than about 1000 pm, such as no greater than about 500 pm, such as no greater than about 400 pm, such as no greater than about 350 pm, such as no greater than about 300 pm. In some embodiments, approximately 100% by weight of the particles of any particulate material referenced herein have a particle size as measured by sieve analysis of no greater than about 1000 pm, such as no greater than about 500 pm, such as no greater than about 400 pm, such as no greater than about 350 pm, such as no greater than about 300 pm.
- At least 50% by weight, such as at least 60% by weight, such as at least 70% by weight, such as at least 80% by weight, such as at least 90% by weight, such as at least 95% by weight, such as at least 99% by weight of the particles of any particulate material referenced herein have a particle size as measured by sieve analysis of from about 0.01 pm to about 1000 pm, such as from about 0.05 pm to about 750 pm, such as from about 0.1 pm to about 500 pm, such as from about 0.25 pm to about 500 pm.
- At least 50% by weight, such as at least 60% by weight, such as at least 70% by weight, such as at least 80% by weight, such as at least 90% by weight, such as at least 95% by weight, such as at least 99% by weight of the particles of any particulate material referenced herein have a particle size as measured by sieve analysis of from about 10 pm to about 400 pm, such as from about 50 pm to about 350 pm, such as from about 100 pm to about 350 pm, such as from about 200 pm to about 300 pm.
- the various components of the composition may vary.
- various combinations of dry ingredients typically including the fdler component, will be blended to form a dry mix. Thereafter, typically in multiple steps, the remaining liquid ingredients are added to the dry mix to prepare the final product mixture.
- the active ingredient e.g., nicotine
- a humectant e.g., propylene glycol or olive oil
- the use of a mixture of certain active ingredients, such as nicotine, with a humectant can reduce mouth or throat irritation associated with oral use of the resulting product.
- the capsules can be added at various stages, such as addition to the dry mix or addition to the product composition immediately before final packaging (e.g., pouching) or after placement of the composition in a pouch (but before pouch sealing).
- mixing efficiency and/or uniformity of the product can be enhanced by using multiple, successive addition steps in the process to add liquid components (e.g., aqueous solutions or dispersions) to the dry mix.
- liquid components e.g., aqueous solutions or dispersions
- Improved mixing efficiency and/or product uniformity can also be provided, in certain embodiments, through use of aqueous compositions at elevated temperature, such as between about 50 to about 100 °C, including about 55 to about 80 °C or about 60 to about 70 °C.
- aqueous compositions used in the process are maintained at room temperature or below, such as between about 10 to about 25 °C, including about 20 to about 25 °C (room temperature).
- room temperature such as between about 10 to about 25 °C, including about 20 to about 25 °C (room temperature).
- use of lower aqueous composition temperatures dining mixing does not cause significant loss in product uniformity or mixing efficiency, and can reduce overall process cost, particularly where room temperature water is used.
- a large percentage of the total amount of water used in the product is added in a final water addition step, particularly after active ingredients and/or flavoring agents are added.
- This type of process is particularly well-suited for use with lower temperature water as noted above.
- applying a large percentage of the total amount of water after addition of all, or virtually all, other ingredients does not cause significant loss in product uniformity or mixing efficiency, and can provide the added benefit of removing residual active ingredient and/or flavoring agent from the pipes in the mixing system without the need for a separate rinsing step that could lead to an undesirable increase in water use or loss in process efficiency.
- the amount of water added in the final water addition step is at least about 50% by weight of the total water content of the product mixture (such as at least about 60% or at least about 65% or at least about 70% or at least about 75% or at least about 80% or at least about 85% or at least about 90%).
- the various components of the composition may be contacted, combined, or mixed together using any mixing technique or equipment known in the art.
- Any mixing method that brings the mixture ingredients into intimate contact can be used, such as a mixing apparatus featuring an impeller or other structure capable of agitation.
- mixing equipment include casing drums, conditioning cylinders or drums, liquid spray apparatus, conical-type blenders, ribbon blenders, mixers available as FKM130, FKM600, FKM1200, FKM2000 and FKM3000 from Fittleford Day, Inc., Plough Share types of mixer cylinders, Hobart mixers, and the like. See, for example, the types of methodologies set forth in US Pat. No. 4,148,325 to Solomon et ak; US Pat. No.
- the present disclosure includes a dosing system that reduces the time spent handling active ingredients.
- An embodiment of the dosing system 20 is shown in Fig. 3.
- the system includes a storage tank 22 for the active ingredient, the storage tank in fluid communication with a dosing tank 30.
- the storage tank 22 can also be in fluid communication with an inert gas container 26 containing an inert gas such as nitrogen, which enables the creation of an inert gas blanket 24 in the headspace over the active ingredient stored in the storage tank 22.
- a pump 28 is used to transport the liquid active ingredient from the storage tank 22 to the dosing tank 30.
- One or more additional storage tanks are advantageously in fluid communication with the dosing tank 30, such as a storage tank 32 for a flavoring agent and a storage tank 34 for a humectant.
- additional components of a composition can be premixed with the active ingredient in the dosing tank 30.
- the active ingredient (optionally premixed with additional components) can be transported to one or more mixing tanks 36, which contain additional components of the desired composition, such as a dry mix as described above.
- a product configured for oral use.
- the term "configured for oral use” as used herein means that the product is provided in a form such that during use, saliva in the mouth of the user causes one or more of the components of the composition (e.g., flavoring agents and/or nicotine) to pass into the mouth of the user.
- the product is adapted to deliver components to a user through mucous membranes in the user's mouth and, in some instances, said component is an active ingredient (including, but not limited to, for example, nicotine) that can be absorbed through the mucous membranes in the mouth when the product is used.
- Products configured for oral use as described herein may take various forms, including gels, pastilles, gums, lozenges, powders, and pouches. Gels can be soft or hard. Certain products configured for oral use are in the form of pastilles. As used herein, the term "pastille” refers to a dissolvable oral product made by solidifying a liquid or gel composition so that the final product is a somewhat hardened solid gel. The rigidity of the gel is highly variable. Certain products of the disclosure are in the form of solids. Certain products can exhibit, for example, one or more of the following characteristics: crispy, granular, chewy, syrupy, pasty, fluffy, smooth, and/or creamy.
- the desired textural property can be selected from the group consisting of adhesiveness, cohesiveness, density, dryness, fracturability, graininess, gumminess, hardness, heaviness, moisture absorption, moisture release, mouthcoating, roughness, slipperiness, smoothness, viscosity, wetness, and combinations thereof.
- the products comprising the compositions of the present disclosure may be dissolvable.
- dissolve refers to compositions having aqueous-soluble components that interact with moisture in the oral cavity and enter into solution, thereby causing gradual consumption of the product.
- the dissolvable product is capable of lasting in the user’s mouth for a given period of time until it completely dissolves. Dissolution rates can vary over a wide range, from about 1 minute or less to about 60 minutes.
- fast release compositions typically dissolve and/or release the active substance in about 2 minutes or less, often about 1 minute or less (e.g., about 50 seconds or less, about 40 seconds or less, about 30 seconds or less, or about 20 seconds or less). Dissolution can occur by any means, such as melting, mechanical disruption (e.g., chewing), enzymatic or other chemical degradation, or by disruption of the interaction between the components of the composition.
- the product can be meltable as discussed, for example, in US Patent App. Pub. No. 2012/0037175 to Cantrell et al.
- the products do not dissolve during the product’s residence in the user’s mouth.
- the product comprising the composition of the present disclosure is in the form of a composition disposed within a moisture-permeable container (e.g., a water-permeable pouch).
- a moisture-permeable container e.g., a water-permeable pouch
- Such compositions in the water-permeable pouch format are typically used by placing one pouch containing the composition in the mouth of a human subject/user.
- the pouch is placed somewhere in the oral cavity of the user, for example under the lips, in the same way as moist snuff products are generally used.
- the pouch preferably is not chewed or swallowed.
- the components of the composition therein e.g., flavoring agents and/or nicotine
- the pouch may be removed from the mouth of the human subject for disposal.
- the composition as disclosed herein and any other components noted above are combined within a moisture-permeable packet or pouch that acts as a container for use of the composition to provide a pouched product configured for oral use.
- a moisture-permeable packet or pouch that acts as a container for use of the composition to provide a pouched product configured for oral use.
- the composition/construction of such packets or pouches may be varied.
- a first embodiment of a pouched product 10 includes a moisture-permeable container in the form of a pouch 12, which contains a composition 14 as described herein.
- the pouched product 10 optionally includes one or more capsules 16 dispersed within the composition 14, the capsules containing an additive (e.g., a flavoring agent) such as described in greater detail below.
- an additive e.g., a flavoring agent
- Suitable packets, pouches or containers of the type used for the manufacture of smokeless tobacco products are available under the tradenames CatchDry, Ettan, General, Granit, Goteborgs Rape, Grovsnus White, Metropol Kaktus, Mocca Anis, Mocca Mint, Mocca Wintergreen, Kicks, Probe, Prince, Skruf and TreAnkrare.
- the composition may be contained in pouches and packaged, in a manner and using the types of components used for the manufacture of conventional snus types of products.
- the pouch provides a liquid-permeable container of a type that may be considered to be similar in character to the mesh-like type of material that is used for the construction of a tea bag. Components of the composition readily diffuse through the pouch and into the mouth of the user.
- Non-limiting examples of suitable types of pouches are set forth in, for example, US Pat. Nos. 5,167,244 to Kjerstad and 8,931,493 to Sebastian et al.; as well as US Patent App. Pub. Nos. 2016/0000140 to Sebastian et al.; 2016/0073689 to Sebastian et al.; 2016/0157515 to Chapman et al.; and 2016/0192703 to Sebastian et al., each of which are incorporated herein by reference.
- Pouches can be provided as individual pouches, or a plurality of pouches (e.g., 2, 4, 5, 10, 12, 15, 20, 25 or 30 pouches) can be connected or linked together (e.g., in an end-to-end manner) such that a single pouch or individual portion can be readily removed for use from a one-piece strand or matrix of pouches.
- a plurality of pouches e.g., 2, 4, 5, 10, 12, 15, 20, 25 or 30 pouches
- An example pouch may be manufactured from materials, and in such a manner, such that during use by the user, the pouch undergoes a controlled dispersion or dissolution.
- Such pouch materials may have the form of a mesh, screen, perforated paper, permeable fabric, or the like.
- pouch material manufactured from a mesh-like form of rice paper, or perforated rice paper may dissolve in the mouth of the user.
- the pouch and composition each may undergo complete dispersion within the mouth of the user during normal conditions of use, and hence the pouch and composition both may be ingested or absorbed by the user.
- pouch materials may be manufactured using water dispersible fdm forming materials (e.g., binding agents such as alginates, carboxymethylcellulose, xanthan gum, pullulan, and the like), as well as those materials in combination with materials such as ground cellulosics (e.g., fine particle size wood pulp).
- Preferred pouch materials though water dispersible or dissolvable, may be designed and manufactured such that under conditions of normal use, a significant amount of the composition contents permeate through the pouch material prior to the time that the pouch undergoes loss of its physical integrity.
- flavoring ingredients, disintegration aids, and other desired components may be incorporated within, or applied to, the pouch material.
- the amount of material contained within each product unit may vary.
- the weight of the composition within each pouch is at least about 50 mg, for example, from about 50 mg to about 1 gram, from about 100 to 800 about mg, or from about 200 to about 700 mg.
- the weight of the composition within each pouch may be from about 100 to about 300 mg.
- the weight of the material within each pouch may be from about 300 mg to about 700 mg.
- each pouch can contain at least one flavored strip, piece or sheet of flavored water dispersible or water soluble material (e.g., a breath-freshening edible film type of material) may be disposed within each pouch along with or without at least one capsule.
- flavored water dispersible or water soluble material e.g., a breath-freshening edible film type of material
- Such strips or sheets may be folded or crumpled in order to be readily incorporated within the pouch. See, for example, the types of materials and technologies set forth in US Pat. Nos. 6,887,307 to Scott et al. and 6,923,981 to Leung et al.; and The EFSA Journal (2004) 85, 1-32; which are incorporated herein by reference.
- any of the types of composition components described above can be added in an encapsulated form (e.g., in the form of capsules including microcapsules), the encapsulated form including a wall or barrier structure defining an inner region and isolating the inner region permanently or temporarily from the remainder of the product composition.
- the inner region includes a payload of an additive either adapted for enhancing one or more sensory characteristics of the product, such as taste, mouthfeel, moistness, coolness/heat, and/or fragrance, or adapted for adding an additional functional quality to the product, such as addition of an antioxidant or immune system enhancing function. See, for example, the subject matter of US Pat. Appl. Pub. No. 2009/0025738 to Mua et al., which is incorporated herein by reference.
- a capsule physically separates or segregates, to a certain extent, an additive from one or more other components of the product.
- the functional advantage of such a separation can vary, but typically involves the minimization or elimination of chemical interaction between the additive and other components of the product during conditions of normal storage and/or use. Separation of certain additives can thus enhance storage stability of the resulting product and/or preserve the desirable sensory characteristics of the product.
- the outer shell of the capsule serves as a barrier between the payload (i.e., the additive) and the remainder of the composition of the product.
- the additive in the core region of the capsule is released under certain conditions of product use. For instance, the outer shell may undergo some type of physical destruction, breakage, or other loss of physical integrity (e.g., through disintegration, softening, crushing, application of pressure, or the like) in response to a trigger condition associated with the product. Such a release of the additive may alter or enhance the flavor or other sensory characteristics of the product, extend the period of time that a user may enjoy the product, or provide other functional advantages.
- the trigger conditions associated with release of the additive may vary, and can include for example, a change in temperature or pH of the product, contact with a digestive enzyme, or physical rupture or breakage caused, for example, by chewing action of the product user.
- contact of the capsule with the raised temperature of the user's mouth may cause the capsule to soften, lose its physical integrity, and release the additive within the user's mouth (e.g., at a temperature of about 37°C or higher).
- the capsule is configured to release the additive in response to a change in pH, such as a capsule configured to release the additive when the pH of the capsule is at or near (e.g., greater than) a pH typical of a user's mouth (e.g., approximately 5.6 to 7.9).
- the capsule is configured to release the additive in response to a digestive enzyme typically found in the mouth of a user (e.g., amylase).
- the capsules may be uniform or varied in size, weight, and shape, and such properties of the capsules will depend upon the desired properties of the product.
- the capsules may be of various shape, including being generally spherical, rectilinear, oblong, elliptical, or oval.
- the size of the capsules can vary, and will include diameter ranges such as about 0.5 to about 5 mm, as well as microcapsule size ranges such as diameters of less than about 100 microns, such as diameters in the range of about 1 to about 40 microns, or about 1 micron to about 20 microns.
- the total weight of the capsules within the product may vary, but is typically between about 10 mg to about 200 mg, such as about 20 mg to about 50 mg.
- the number of the capsules utilized in each product can vary, depending upon factors such as the size of the capsules, the character or nature of the additive in the payload, the desired attributes of the product, and the like.
- the number of capsules will typically range from 1 to about 500, more typically about 5 to about 100.
- the outer wall or shell material used to form the capsules can vary.
- Classes of materials that are typically used as wall or shell materials include proteins, polysaccharides, starches, waxes, fats, natural and synthetic polymers, and resins.
- Example materials include gelatin, natural gums, polyvinyl acetate, potassium or sodium alginate, carrageenan, dextrin, polyvinyl alcohol, povidone, dimethylpolysiloxane, paraffin wax, shellac, cellulose derivatives (e.g., ethylcellulose, carboxymethylcellulose, hydroxypropyl cellulose, hydroxypropylmethylcellulose, methylcellulose, methyl ethyl cellulose), microcrystalline wax, terpene resin, tragacanth, polyethylene, and polyethylene glycol.
- cellulose derivatives e.g., ethylcellulose, carboxymethylcellulose, hydroxypropyl cellulose, hydroxypropylmethylcellulose, methylcellulose, methyl ethyl cellulose
- the capsule may include an additional outer coating on the outer shell, such as a coating adapted to increase water resistance.
- Example coating materials include various polymer materials, such as cellulose derivatives (e.g., HPMC), polyvinyl alcohol, and acrylate or methacrylate polymers.
- a pouched product as described herein can be packaged within any suitable inner packaging material and/or outer container. See also, for example, the various types of containers for smokeless types of products that are set forth in US Pat. Nos. 7,014,039 to Henson et al.; 7,537,110 to Kutsch et al.; 7,584,843 to Kutsch et al.; 8,397,945 to Gelardi et al., D592,956 to Thiellier; D594,154 to Patel et al.; and D625,178 to Bailey et al.; US Pat. Pub. Nos.
- An oral composition comprising the ingredients set forth in Table 1 below is prepared. The actual ingredient percentages can be varied depending the desired final product.
- composition is prepared using the following method:
- the MCC, sodium alginate, and sodium chloride are put into a paddle blender and blended to form a dry mix.
- sodium bicarbonate is mixed with about half of the total water to be used in the recipe (e.g., water at an elevated temperature of about 65 °C). The mixture is stirred until the sodium bicarbonate fully dissolves to form an aqueous solution.
- the sodium bicarbonate solution is then sprayed from a pressure vessel on the dry mix in the blender and the resulting mixture is blended for about 5 minutes.
- xylitol, ammonium chloride as a pH adjuster, potassium sorbate as a preservative, and an artificial sweetener e.g., sucralose or acesulfame K
- an artificial sweetener e.g., sucralose or acesulfame K
- Step 4 In a separate container, a flavoring agent, propylene glycol, and nicotine are mixed together and then added to the solution of Step 4.
- Step 5 The mixture of Step 5 is then sprayed from a pressure vessel on the mixture from Step 3 in the blender, and the resulting mixture is blended for about 10 minutes.
- xylitol, ammonium chloride as a pH adjuster, potassium sorbate as a preservative, and an artificial sweetener e.g., sucralose or acesulfame K
- an artificial sweetener e.g., sucralose or acesulfame K
- Step 7 The mixture of Step 7 is then sprayed from a pressure vessel on the mixture from Step 6 in the blender, and the resulting mixture is blended for about 10 minutes.
- composition is prepared using the following method:
- the MCC, sodium alginate, bleached tobacco, and sodium chloride are put into a paddle blender and blended to form a dry mix.
- sodium bicarbonate is mixed with about half of the total water to be used in the recipe (e.g., water at an elevated temperature of about 65 °C). The mixture is stirred until the sodium bicarbonate fully dissolves to form an aqueous solution.
- the sodium bicarbonate solution is then sprayed from a pressure vessel on the dry mix in the blender and the resulting mixture is blended for about 5 minutes. 4.
- xylitol, ammonium chloride as a pH adjuster, potassium sorbate as a preservative, and an artificial sweetener e.g., sucralose or acesulfame K
- an artificial sweetener e.g., sucralose or acesulfame K
- Step 5 is then sprayed from a pressure vessel on the mixture from Step 3 in the blender, and the resulting mixture is blended for about 10 minutes.
- xylitol, ammonium chloride as a pH adjuster, potassium sorbate as a preservative, and an artificial sweetener e.g., sucralose or acesulfame K
- an artificial sweetener e.g., sucralose or acesulfame K
- the mixture of Step 7 is then sprayed from a pressure vessel on the mixture from Step 6 in the blender, and the resulting mixture is blended for about 10 minutes.
- An oral composition comprising the ingredients set forth in Table 3 below is prepared. The actual ingredient percentages can be varied depending the desired final product.
- composition is prepared using the following method:
- the MCC, sodium alginate, bleached tobacco, guar gum, and sodium chloride are put into a paddle blender and blended to form a dry mix.
- sodium bicarbonate is mixed with about half of the total water to be used in the recipe (e.g., water at an elevated temperature of about 65 °C). The mixture is stirred until the sodium bicarbonate fully dissolves to form an aqueous solution. 3. The sodium bicarbonate solution is then sprayed from a pressure vessel on the dry mix in the blender and the resulting mixture is blended for about 5 minutes.
- xylitol, ammonium chloride as a pH adjuster, potassium sorbate as a preservative, and an artificial sweetener e.g., sucralose or acesulfame K
- an artificial sweetener e.g., sucralose or acesulfame K
- Step 5 The mixture of Step 5 is then sprayed from a pressure vessel on the mixture from Step 3 in the blender, and the resulting mixture is blended for about 10 minutes.
- the resulting mixture is then removed from the blender and placed into storage containers for future pouching.
- An oral composition comprising the ingredients set forth in Table 4 below is prepared. The actual ingredient percentages can be varied depending the desired final product.
- composition is prepared using the following method: 1.
- the MCC, bleached tobacco, guar gum, artificial sweetener (e.g., sucralose or acesulfame K), sodium bicarbonate, potassium sorbate, and sodium chloride are put into a paddle blender and blended to form a dry mix.
- sodium alginate is mixed with water (e.g., water at an elevated temperature of about 65 °C). The mixture is stirred until the sodium alginate fully dissolves to form an aqueous solution. Xylitol is then added and mixed until dissolved.
- water e.g., water at an elevated temperature of about 65 °C.
- Step 2 The solution from Step 2 is then sprayed from a pressure vessel on the dry mix in the blender and the resulting mixture is blended for about 5 minutes.
- Step 4 The mixture of Step 4 is then sprayed from a pressure vessel on the mixture from Step 3 in the blender, and the resulting mixture is blended for about 10 minutes.
- the resulting mixture is then removed from the blender and placed into storage containers for future pouching.
- An oral composition comprising the ingredients set forth in Example 1 is prepared using the following method:
- the MCC, sodium chloride, xylitol, sodium alginate, sodium bicarbonate, artificial sweetener, and potassium sorbate are put into a paddle blender and blended to form a dry mix.
- a nicotine solution is mixed with propylene glycol and then sprayed from a pressure vessel on the dry mix in the blender and the resulting mixture is blended for about 5 minutes.
- a flavoring agent is then sprayed from a pressure vessel on the mixture in the blender and the resulting mixture is blended for about 5 minutes.
- All water used in the composition is then sprayed from a pressure vessel on the mixture in the blender and the resulting mixture is blended for about 10 minutes.
- the water is not heated, and is typically at room temperature or below.
- the resulting mixture is then removed from the blender and placed into storage containers for future pouching.
- An oral composition comprising the ingredients set forth in Example 2 is prepared using the following method: 1.
- the MCC, sodium chloride, xylitol, bleached tobacco, sodium alginate, sodium bicarbonate, artificial sweetener, and potassium sorbate are put into a paddle blender and blended to form a dry mix.
- a nicotine solution is then sprayed from a pressure vessel on the dry mix in the blender and the resulting mixture is blended for about 5 minutes.
- a flavoring agent is then sprayed from a pressure vessel on the mixture in the blender and the resulting mixture is blended for about 5 minutes.
- All remaining water used in the composition is then sprayed from a pressure vessel on the mixture in the blender and the resulting mixture is blended for about 10 minutes.
- the water is not heated, and is typically at room temperature or below.
- the resulting mixture is then removed from the blender and placed into storage containers for future pouching.
- An oral composition comprising the ingredients set forth in Example 3 is prepared using the following method:
- the MCC, sodium chloride, xylitol, guar gum, bleached tobacco, sodium alginate, sodium bicarbonate, artificial sweetener, and potassium sorbate are put into a paddle blender and blended to form a dry mix.
- a nicotine solution is then sprayed from a pressure vessel on the dry mix in the blender and the resulting mixture is blended for about 5 minutes.
- a flavoring agent is then sprayed from a pressure vessel on the mixture in the blender and the resulting mixture is blended for about 5 minutes.
- All remaining water used in the composition is then sprayed from a pressure vessel on the mixture in the blender and the resulting mixture is blended for about 10 minutes.
- the water is not heated, and is typically at room temperature or below.
- the resulting mixture is then removed from the blender and placed into storage containers for future pouching.
- An oral composition comprising the ingredients set forth in Example 4 is prepared using the following method: 1.
- the MCC, sodium chloride, xylitol, guar gum, bleached tobacco, sodium alginate, sodium bicarbonate, artificial sweetener, and potassium sorbate are put into a paddle blender and blended to form a dry mix.
- a nicotine solution is mixed with propylene glycol and then sprayed from a pressure vessel on the dry mix in the blender and the resulting mixture is blended for about 5 minutes.
- a flavoring agent is then sprayed from a pressure vessel on the mixture in the blender and the resulting mixture is blended for about 5 minutes.
- All remaining water used in the composition is then sprayed from a pressure vessel on the mixture in the blender and the resulting mixture is blended for about 10 minutes.
- the water is not heated, and is typically at room temperature or below.
- the resulting mixture is then removed from the blender and placed into storage containers for future pouching.
- Example 9 Irritation Reduction Pouched product samples were made containing the same amounts of microcrystalline cellulose, sodium chloride, alginate, and acesulfame K. Three sets of samples were prepared using this same base formulation, including: (1) pouches with 4 mg nicotine and 4 mg propylene glycol (PG) added; (2) pouches with 4 mg nicotine and 4 mg olive oil added; and (3) pouches with 4 mg nicotine only added (no propylene glycol or olive oil).
- the sensory evaluation was conducted by requesting panelists to choose the most irritating and the least irritating sample. The collected data was used to generate the data presented in Fig. 2. The trend line indicates that there is lower irritation level for the samples containing either propylene glycol or olive oil.
Landscapes
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Toxicology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Agronomy & Crop Science (AREA)
- Botany (AREA)
- Manufacture Of Tobacco Products (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
Claims
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MX2022005285A MX2022005285A (en) | 2019-10-31 | 2019-10-31 | ORAL PRODUCT AND MANUFACTURING METHOD. |
JP2022525354A JP7702942B2 (en) | 2019-10-31 | 2019-10-31 | Oral Products and Methods of Manufacturing |
EP19805860.4A EP4051020B1 (en) | 2019-10-31 | 2019-10-31 | Oral product and method of manufacture |
PCT/US2019/059090 WO2021086367A1 (en) | 2019-10-31 | 2019-10-31 | Oral product and method of manufacture |
CA3156573A CA3156573A1 (en) | 2019-10-31 | 2019-10-31 | Oral product and method of manufacture |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US2019/059090 WO2021086367A1 (en) | 2019-10-31 | 2019-10-31 | Oral product and method of manufacture |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2021086367A1 true WO2021086367A1 (en) | 2021-05-06 |
Family
ID=68610360
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2019/059090 WO2021086367A1 (en) | 2019-10-31 | 2019-10-31 | Oral product and method of manufacture |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP4051020B1 (en) |
JP (1) | JP7702942B2 (en) |
CA (1) | CA3156573A1 (en) |
MX (1) | MX2022005285A (en) |
WO (1) | WO2021086367A1 (en) |
Cited By (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20210169889A1 (en) * | 2019-12-09 | 2021-06-10 | Nicoventures Trading Limited | Oral products |
US20210259299A1 (en) * | 2020-02-24 | 2021-08-26 | Nicoventures Trading Limited | Beaded Tobacco Material and Related Method of Manufacture |
EP3809884B1 (en) | 2019-06-07 | 2022-09-21 | Philip Morris Products S.A. | Nicotine pouch product |
WO2023281469A1 (en) * | 2021-07-09 | 2023-01-12 | Nicoventures Trading Limited | Extruded structures |
US11793230B2 (en) | 2019-12-09 | 2023-10-24 | Nicoventures Trading Limited | Oral products with improved binding of active ingredients |
US11826462B2 (en) | 2019-12-09 | 2023-11-28 | Nicoventures Trading Limited | Oral product with sustained flavor release |
US11969502B2 (en) | 2019-12-09 | 2024-04-30 | Nicoventures Trading Limited | Oral products |
DK181550B1 (en) * | 2022-01-28 | 2024-05-02 | Mac Baren Tobacco Company As | Method for producing a pouch composition |
WO2024160334A1 (en) * | 2023-02-03 | 2024-08-08 | Fertin Pharma A/S | A nicotine pouch composition |
US12064424B2 (en) | 2019-12-09 | 2024-08-20 | Nicoventures Trading Limited | Moist oral compositions |
EP4072330B1 (en) | 2019-12-09 | 2024-12-11 | Nicoventures Trading Limited | Oral products with reduced irritation |
DK181787B1 (en) * | 2022-01-28 | 2025-01-03 | Mac Baren Tobacco Company As | Bag composition comprising one or more water-insoluble fibers |
US12295412B2 (en) | 2022-01-28 | 2025-05-13 | Altria Client Services Llc | Oral pouch product |
US12310959B2 (en) | 2019-12-09 | 2025-05-27 | Nicoventures Trading Limited | Oral compositions with reduced water content |
US12382982B2 (en) | 2021-06-25 | 2025-08-12 | Nicoventures Trading Limited | Oral products and method of manufacture |
Citations (168)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US787611A (en) | 1903-06-17 | 1905-04-18 | American Cigar Company | Treating tobacco. |
US1086306A (en) | 1912-11-11 | 1914-02-03 | Theodor Oelenheinz | Process of bleaching tobacco-leaves. |
US1376586A (en) | 1918-04-06 | 1921-05-03 | Schwartz Francis | Tobacco-tablet |
US1437095A (en) | 1920-06-01 | 1922-11-28 | August Wasmuth | Process of bleaching tobacco |
US1757477A (en) | 1927-07-11 | 1930-05-06 | Rosenhoch Samuel | Process and device for ozonizing tobacco |
US2033909A (en) | 1934-12-19 | 1936-03-17 | Niacet Chemicals Corp | Manufacture of calcium levulinate |
US2122421A (en) | 1937-07-30 | 1938-07-05 | Du Pont | Tobacco treatment |
US2148147A (en) | 1933-12-30 | 1939-02-21 | Degussa | Process for bleaching tobacco |
US2170107A (en) | 1935-01-28 | 1939-08-22 | Degussa | Process for bleaching tobacco |
US2274649A (en) | 1935-01-28 | 1942-03-03 | Degussa | Process for bleaching tobacco |
US2770239A (en) | 1952-02-04 | 1956-11-13 | Prats Jose Romero | Process of treating tobacco |
US3612065A (en) | 1970-03-09 | 1971-10-12 | Creative Enterprises Inc | Method of puffing tobacco and reducing nicotine content thereof |
US3851653A (en) | 1972-10-11 | 1974-12-03 | Rosen Enterprises Inc | Method of puffing tobacco and reducing nicotine content thereof |
US3889689A (en) | 1971-12-20 | 1975-06-17 | Rosen Enterprise Inc | Method of treating tobacco with catalase and hydrogen peroxide |
US3901248A (en) | 1970-07-22 | 1975-08-26 | Leo Ab | Chewable smoking substitute composition |
US3943945A (en) | 1971-09-20 | 1976-03-16 | Rosen Enterprises, Inc. | Process for preparation of reconstituted tobacco sheet |
US3943940A (en) | 1974-09-13 | 1976-03-16 | Isao Minami | Method of removing nicotine in smoking and a smoking filter to be used therefor |
US4143666A (en) | 1975-08-15 | 1979-03-13 | Philip Morris Incorporated | Smoking material |
US4144895A (en) | 1974-03-08 | 1979-03-20 | Amf Incorporated | Solvent extraction process |
US4148325A (en) | 1975-08-18 | 1979-04-10 | British-American Tobacco Company Limited | Treatment of tobacco |
US4150677A (en) | 1977-01-24 | 1979-04-24 | Philip Morris Incorporated | Treatment of tobacco |
US4194514A (en) | 1976-09-27 | 1980-03-25 | Stauffer Chemical Company | Removal of radioactive lead and polonium from tobacco |
US4267847A (en) | 1978-05-12 | 1981-05-19 | British-American Tobacco Company Limited | Tobacco additives |
US4289147A (en) | 1979-11-15 | 1981-09-15 | Leaf Proteins, Inc. | Process for obtaining deproteinized tobacco freed of nicotine and green pigment, for use as a smoking product |
US4340073A (en) | 1974-02-12 | 1982-07-20 | Philip Morris, Incorporated | Expanding tobacco |
US4351346A (en) | 1980-03-08 | 1982-09-28 | B.A.T. Cigaretten-Fabriken Gmbh | Process for the preparation of aromatic substances |
US4359059A (en) | 1980-03-08 | 1982-11-16 | B.A.T. Cigaretten-Fabriken Gmbh | Process for the preparation of aromatic substances |
US4366824A (en) | 1981-06-25 | 1983-01-04 | Philip Morris Incorporated | Process for expanding tobacco |
US4366823A (en) | 1981-06-25 | 1983-01-04 | Philip Morris, Incorporated | Process for expanding tobacco |
US4388933A (en) | 1981-06-25 | 1983-06-21 | Philip Morris, Inc. | Tobacco stem treatment and expanded tobacco product |
US4506682A (en) | 1981-12-07 | 1985-03-26 | Mueller Adam | Clear tobacco aroma oil, a process for obtaining it from a tobacco extract, and its use |
US4513756A (en) | 1983-04-28 | 1985-04-30 | The Pinkerton Tobacco Company | Process of making tobacco pellets |
US4528993A (en) | 1982-08-20 | 1985-07-16 | R. J. Reynolds Tobacco Company | Process for producing moist snuff |
US4589428A (en) | 1980-02-21 | 1986-05-20 | Philip Morris Incorporated | Tobacco treatment |
US4605016A (en) | 1983-07-21 | 1986-08-12 | Japan Tobacco, Inc. | Process for preparing tobacco flavoring formulations |
US4624269A (en) | 1984-09-17 | 1986-11-25 | The Pinkerton Tobacco Company | Chewable tobacco based product |
US4641667A (en) | 1983-12-09 | 1987-02-10 | B.A.T. Cigarettenfabriken Gmbh | Process of preparing nicotine N'-oxide and smoking products containing it |
US4660577A (en) | 1982-08-20 | 1987-04-28 | R.J. Reynolds Tobacco Company | Dry pre-mix for moist snuff |
US4716911A (en) | 1986-04-08 | 1988-01-05 | Genencor, Inc. | Method for protein removal from tobacco |
US4725440A (en) | 1982-07-02 | 1988-02-16 | E. R. Squibb & Sons, Inc. | Antifungal pastille formulation and method |
US4727889A (en) | 1986-12-22 | 1988-03-01 | R. J. Reynolds Tobacco Company | Tobacco processing |
US4887618A (en) | 1988-05-19 | 1989-12-19 | R. J. Reynolds Tobacco Company | Tobacco processing |
US4941484A (en) | 1989-05-30 | 1990-07-17 | R. J. Reynolds Tobacco Company | Tobacco processing |
US4967771A (en) | 1988-12-07 | 1990-11-06 | R. J. Reynolds Tobacco Company | Process for extracting tobacco |
US4986286A (en) | 1989-05-02 | 1991-01-22 | R. J. Reynolds Tobacco Company | Tobacco treatment process |
US4987907A (en) | 1988-06-29 | 1991-01-29 | Helme Tobacco Company | Chewing tobacco composition and process for producing same |
US4991599A (en) | 1989-12-20 | 1991-02-12 | Tibbetts Hubert M | Fiberless tobacco product for smoking and chewing |
US5005593A (en) | 1988-01-27 | 1991-04-09 | R. J. Reynolds Tobacco Company | Process for providing tobacco extracts |
US5018540A (en) | 1986-12-29 | 1991-05-28 | Philip Morris Incorporated | Process for removal of basic materials |
US5060669A (en) | 1989-12-18 | 1991-10-29 | R. J. Reynolds Tobacco Company | Tobacco treatment process |
US5065775A (en) | 1990-02-23 | 1991-11-19 | R. J. Reynolds Tobacco Company | Tobacco processing |
US5074319A (en) | 1990-04-19 | 1991-12-24 | R. J. Reynolds Tobacco Company | Tobacco extraction process |
US5092352A (en) | 1983-12-14 | 1992-03-03 | American Brands, Inc. | Chewing tobacco product |
US5099862A (en) | 1990-04-05 | 1992-03-31 | R. J. Reynolds Tobacco Company | Tobacco extraction process |
US5121757A (en) | 1989-12-18 | 1992-06-16 | R. J. Reynolds Tobacco Company | Tobacco treatment process |
US5131414A (en) | 1990-02-23 | 1992-07-21 | R. J. Reynolds Tobacco Company | Tobacco processing |
US5131415A (en) | 1991-04-04 | 1992-07-21 | R. J. Reynolds Tobacco Company | Tobacco extraction process |
US5148819A (en) | 1991-08-15 | 1992-09-22 | R. J. Reynolds Tobacco Company | Process for extracting tobacco |
US5167244A (en) | 1990-01-19 | 1992-12-01 | Kjerstad Randy E | Tobacco substitute |
US5197494A (en) | 1991-06-04 | 1993-03-30 | R.J. Reynolds Tobacco Company | Tobacco extraction process |
US5230354A (en) | 1991-09-03 | 1993-07-27 | R. J. Reynolds Tobacco Company | Tobacco processing |
US5234008A (en) | 1990-02-23 | 1993-08-10 | R. J. Reynolds Tobacco Company | Tobacco processing |
US5243999A (en) | 1991-09-03 | 1993-09-14 | R. J. Reynolds Tobacco Company | Tobacco processing |
US5259403A (en) | 1992-03-18 | 1993-11-09 | R. J. Reynolds Tobacco Company | Process and apparatus for expanding tobacco cut filler |
US5301694A (en) | 1991-11-12 | 1994-04-12 | Philip Morris Incorporated | Process for isolating plant extract fractions |
US5318050A (en) | 1991-06-04 | 1994-06-07 | R. J. Reynolds Tobacco Company | Tobacco treatment process |
US5343879A (en) | 1991-06-21 | 1994-09-06 | R. J. Reynolds Tobacco Company | Tobacco treatment process |
US5360022A (en) | 1991-07-22 | 1994-11-01 | R. J. Reynolds Tobacco Company | Tobacco processing |
US5387416A (en) | 1993-07-23 | 1995-02-07 | R. J. Reynolds Tobacco Company | Tobacco composition |
US5435325A (en) | 1988-04-21 | 1995-07-25 | R. J. Reynolds Tobacco Company | Process for providing tobacco extracts using a solvent in a supercritical state |
US5445169A (en) | 1992-08-17 | 1995-08-29 | R. J. Reynolds Tobacco Company | Process for providing a tobacco extract |
US5539093A (en) | 1994-06-16 | 1996-07-23 | Fitzmaurice; Wayne P. | DNA sequences encoding enzymes useful in carotenoid biosynthesis |
WO1996031255A1 (en) | 1995-04-07 | 1996-10-10 | George Giolvas | Method and apparatus for the removal of harmful constituents from cigarettes and tobacco before smoking |
US5668295A (en) | 1990-11-14 | 1997-09-16 | Philip Morris Incorporated | Protein involved in nicotine synthesis, DNA encoding, and use of sense and antisense DNAs corresponding thereto to affect nicotine content in transgenic tobacco cells and plants |
US5705624A (en) | 1995-12-27 | 1998-01-06 | Fitzmaurice; Wayne Paul | DNA sequences encoding enzymes useful in phytoene biosynthesis |
US5713376A (en) | 1996-05-13 | 1998-02-03 | Berger; Carl | Non-addictive tobacco products |
US5844119A (en) | 1994-12-21 | 1998-12-01 | The Salk Institute For Biological Studies | Genetically modified plants having modulated flower development |
US5908032A (en) | 1996-08-09 | 1999-06-01 | R.J. Reynolds Tobacco Company | Method of and apparatus for expanding tobacco |
US6077524A (en) | 1994-05-06 | 2000-06-20 | Bolder Arzneimittel Gmbh | Gastric acid binding chewing pastilles |
US6131584A (en) | 1999-04-15 | 2000-10-17 | Brown & Williamson Tobacco Corporation | Tobacco treatment process |
US6298859B1 (en) | 1998-07-08 | 2001-10-09 | Novozymes A/S | Use of a phenol oxidizing enzyme in the treatment of tobacco |
US6510855B1 (en) | 2000-03-03 | 2003-01-28 | Brown & Williamson Tobacco Corporation | Tobacco recovery system |
US6668839B2 (en) | 2001-05-01 | 2003-12-30 | Jonnie R. Williams | Smokeless tobacco product |
US20040020503A1 (en) | 2001-05-01 | 2004-02-05 | Williams Jonnie R. | Smokeless tobacco product |
US6730832B1 (en) | 2001-09-10 | 2004-05-04 | Luis Mayan Dominguez | High threonine producing lines of Nicotiana tobacum and methods for producing |
US6772767B2 (en) | 2002-09-09 | 2004-08-10 | Brown & Williamson Tobacco Corporation | Process for reducing nitrogen containing compounds and lignin in tobacco |
US20040191322A1 (en) | 2002-12-20 | 2004-09-30 | Henri Hansson | Physically and chemically stable nicotine-containing particulate material |
WO2004095959A1 (en) | 2003-04-29 | 2004-11-11 | Swedish Match North Europe Ab | Oral snuff product and method for producing the same |
US6834654B2 (en) | 2001-05-01 | 2004-12-28 | Regent Court Technologies, Llc | Smokeless tobacco product |
US6887307B1 (en) | 1999-07-22 | 2005-05-03 | Warner-Lambert Company, Llc | Pullulan film compositions |
WO2005041699A2 (en) | 2003-11-03 | 2005-05-12 | U.S. Smokeless Tobacco Company | Flavored smokeless tabacco and methods of making |
US6895974B2 (en) | 1999-04-26 | 2005-05-24 | R. J. Reynolds Tobacco Company | Tobacco processing |
WO2005063060A1 (en) | 2003-12-22 | 2005-07-14 | U.S. Smokeless Tobacco Company | Conditioning process for tobacco and/or snuff compositions |
US6923981B2 (en) | 1998-09-25 | 2005-08-02 | Warner-Lambert Company | Fast dissolving orally consumable films |
US6953040B2 (en) | 2001-09-28 | 2005-10-11 | U.S. Smokeless Tobacco Company | Tobacco mint plant material product |
US20050244521A1 (en) | 2003-11-07 | 2005-11-03 | Strickland James A | Tobacco compositions |
US7014039B2 (en) | 2003-06-19 | 2006-03-21 | R.J. Reynolds Tobacco Company | Sliding shell package for smoking articles |
US7025066B2 (en) | 2002-10-31 | 2006-04-11 | Jerry Wayne Lawson | Method of reducing the sucrose ester concentration of a tobacco mixture |
US7032601B2 (en) | 2001-09-28 | 2006-04-25 | U.S. Smokeless Tobacco Company | Encapsulated materials |
US20060191548A1 (en) | 2003-11-07 | 2006-08-31 | Strickland James A | Tobacco compositions |
US20060236434A1 (en) | 2000-08-30 | 2006-10-19 | North Carolina State University | Methods and compositions for tobacco plants with reduced nicotine |
US20070062549A1 (en) | 2005-09-22 | 2007-03-22 | Holton Darrell E Jr | Smokeless tobacco composition |
US7208659B2 (en) | 2001-05-02 | 2007-04-24 | Conopco Inc. | Process for increasing the flavonoid content of a plant and plants obtainable thereby |
US7230160B2 (en) | 2001-03-08 | 2007-06-12 | Michigan State University | Lipid metabolism regulators in plants |
US20070186941A1 (en) | 2006-02-10 | 2007-08-16 | Holton Darrell E Jr | Smokeless tobacco composition |
US20070186942A1 (en) | 2006-01-31 | 2007-08-16 | U. S. Smokeless Tobacco Company | Tobacco Articles and Methods |
US20080029116A1 (en) | 2006-08-01 | 2008-02-07 | John Howard Robinson | Smokeless tobacco |
US20080029110A1 (en) | 2006-02-10 | 2008-02-07 | R. J. Reynolds Tobacco Company | Smokeless Tobacco Composition |
US7337782B2 (en) | 2004-08-18 | 2008-03-04 | R.J. Reynolds Tobacco Company | Process to remove protein and other biomolecules from tobacco extract or slurry |
US20080173317A1 (en) | 2006-08-01 | 2008-07-24 | John Howard Robinson | Smokeless tobacco |
US20080196730A1 (en) | 2004-07-02 | 2008-08-21 | Radi Medical Systems Ab | Smokeless Tobacco Product |
WO2008103935A2 (en) | 2007-02-23 | 2008-08-28 | U.S. Smokeless Tobacco Company | Novel tobacco compositions and methods of making |
US20080305216A1 (en) | 2007-06-08 | 2008-12-11 | Philip Morris Usa Inc. | Capsule clusters for oral consumption |
US20090014450A1 (en) | 2003-08-18 | 2009-01-15 | Gustavus Ab | Snuff-box lid |
US20090014343A1 (en) | 2007-05-07 | 2009-01-15 | Philip Morris Usa Inc. | Pocket-size hybrid container for consumer items |
US20090025738A1 (en) | 2007-07-23 | 2009-01-29 | R. J. Reynolds Tobacco Company | Smokeless Tobacco Composition |
US20090065013A1 (en) | 2006-04-28 | 2009-03-12 | Swedish Match North Europe Ab | moist snuff non-tobacco composition and a method for producing thereof |
USD592956S1 (en) | 2008-02-08 | 2009-05-26 | Philip Morris Usa Inc. | Container |
US7537110B2 (en) | 2005-06-02 | 2009-05-26 | Philip Morris Usa Inc. | Container for consumer article |
USD594154S1 (en) | 2007-11-13 | 2009-06-09 | R.J. Reynolds Tobacco Company | Container with bottom compartment |
US7556047B2 (en) | 2003-03-20 | 2009-07-07 | R.J. Reynolds Tobacco Company | Method of expanding tobacco using steam |
US7584843B2 (en) | 2005-07-18 | 2009-09-08 | Philip Morris Usa Inc. | Pocket-size hand-held container for consumer items |
US20090223989A1 (en) | 2008-03-04 | 2009-09-10 | R.J. Reynolds Tobacco Company | Dispensing Container |
US20090230003A1 (en) | 2008-02-08 | 2009-09-17 | Philip Morris Usa Inc. | Pocket-sized container |
US20090250360A1 (en) | 2007-11-30 | 2009-10-08 | Philip Morris Usa Inc. | Pocket-size container for consumer items |
US20090266837A1 (en) | 2008-04-25 | 2009-10-29 | R. J. Reynolds Tobacco Company | Dispensing Container |
US20090293889A1 (en) | 2007-11-28 | 2009-12-03 | Philip Morris Usa Inc. | Smokeless compressed tobacco product for oral consumption |
US7650892B1 (en) | 2004-09-03 | 2010-01-26 | Rosswil Llc Ltd. | Methods for hindering formation of tobacco-specific nitrosamines |
US20100084424A1 (en) | 2006-12-12 | 2010-04-08 | John Gelardi | Container with pivoting cover |
US20100133140A1 (en) | 2008-12-01 | 2010-06-03 | Bailey Ryan A | Dual cavity sliding dispenser |
US7798153B2 (en) | 2004-08-23 | 2010-09-21 | Us Smokeless Tobacco Co. | Nicotiana Kawakamii smokeless tobacco |
USD625178S1 (en) | 2009-04-16 | 2010-10-12 | R.J. Reynolds Tobacco Company, Inc. | Container with hinged insert |
US20100264157A1 (en) | 2009-04-16 | 2010-10-21 | R.J. Reynolds Tobacco Company | Dispensing container for metered dispensing of product |
US20100282267A1 (en) | 2009-05-11 | 2010-11-11 | Frank Atchley | Method and device for flavoring smokeless tobacco |
US20100291245A1 (en) | 2008-12-08 | 2010-11-18 | Philip Morris Usa Inc. | Soft, chewable and orally dissolvable and/or disintegrable products |
US20110139164A1 (en) | 2009-12-15 | 2011-06-16 | R. J. Reynolds Tobacco Company | Tobacco Product And Method For Manufacture |
US20110168712A1 (en) | 2010-01-12 | 2011-07-14 | R.J. Reynolds Tobacco Company | Dispensing container |
US20110247640A1 (en) | 2010-04-08 | 2011-10-13 | R. J. Reynolds Tobacco Company | Smokeless Tobacco Composition Comprising Tobacco-Derived Material and Non-Tobacco Plant Material |
US20120037175A1 (en) | 2010-08-11 | 2012-02-16 | R.J. Reynolds Tobacco Company | Meltable smokeless tobacco composition |
US20120055494A1 (en) | 2010-09-07 | 2012-03-08 | Rj Reynolds Tobacco Company | Smokeless Tobacco Product Comprising Effervescent Composition |
US20120067361A1 (en) | 2009-04-03 | 2012-03-22 | X-International Aps | Plant fiber product and method for its manufacture |
US8186360B2 (en) | 2007-04-04 | 2012-05-29 | R.J. Reynolds Tobacco Company | Cigarette comprising dark air-cured tobacco |
US20120138073A1 (en) | 2010-12-01 | 2012-06-07 | Rj Reynolds Tobacco Company | Smokeless tobacco pastille and injection molding process for forming smokeless tobacco products |
US20120138074A1 (en) | 2010-12-01 | 2012-06-07 | Rj Reynolds Tobacco Company | Smokeless tobacco pastille and moulding process for forming smokeless tobacco products |
US8397945B2 (en) | 2010-02-23 | 2013-03-19 | R.J. Reynolds Tobacco Company | Dispensing container |
US20130074855A1 (en) | 2011-09-22 | 2013-03-28 | R.J. Reynolds Tobacco Company | Translucent smokeless tobacco product |
US20130074856A1 (en) | 2011-09-22 | 2013-03-28 | R.J. Reynolds Tobacco Company | Translucent smokeless tobacco product |
US8434496B2 (en) | 2009-06-02 | 2013-05-07 | R. J. Reynolds Tobacco Company | Thermal treatment process for tobacco materials |
US20130152953A1 (en) | 2011-12-14 | 2013-06-20 | R. J. Reynolds Tobacco Company | Smokeless tobacco product comprising effervescent composition |
US20130206153A1 (en) * | 2012-02-13 | 2013-08-15 | R.J. Reynolds Tobacco Company | Whitened tobacco composition |
US20130274296A1 (en) | 2012-04-17 | 2013-10-17 | R.J. Reynolds Tobacco Company | Remelted ingestible products |
US8642016B2 (en) * | 2006-07-21 | 2014-02-04 | Jsrnti, Llc | Medicinal delivery system, and related methods |
US8931493B2 (en) | 2010-11-01 | 2015-01-13 | R.J. Reynolds Tobacco Co. | Smokeless tobacco products |
US8944072B2 (en) | 2009-06-02 | 2015-02-03 | R.J. Reynolds Tobacco Company | Thermal treatment process for tobacco materials |
US20150068545A1 (en) | 2013-09-09 | 2015-03-12 | R.J. Reynolds Tobacco Company | Smokeless tobacco composition incorporating a botanical material |
US8991403B2 (en) | 2009-06-02 | 2015-03-31 | R.J. Reynolds Tobacco Company | Thermal treatment process for tobacco materials |
US20150101627A1 (en) | 2013-10-16 | 2015-04-16 | R.J. Reynolds Tobacco Company | Smokeless tobacco pastille |
US20150230515A1 (en) | 2014-02-14 | 2015-08-20 | R.J. Reynolds Tobacco Company | Tobacco-containing gel composition |
US20160000140A1 (en) | 2014-07-02 | 2016-01-07 | R.J. Reynolds Tobacco Company | Oral pouch products |
US20160073689A1 (en) | 2014-09-12 | 2016-03-17 | R.J. Reynolds Tobacco Company | Nonwoven pouch comprising heat sealable binder fiber |
US20160073686A1 (en) | 2014-09-12 | 2016-03-17 | R.J. Reynolds Tobacco Company | Tobacco-derived filter element |
US9339058B2 (en) | 2012-04-19 | 2016-05-17 | R. J. Reynolds Tobacco Company | Method for producing microcrystalline cellulose from tobacco and related tobacco product |
US20160157515A1 (en) | 2014-12-05 | 2016-06-09 | R.J. Reynolds Tobacco Company | Smokeless tobacco pouch |
US20160192703A1 (en) | 2015-01-07 | 2016-07-07 | R.J. Reynolds Tobacco Company | Oral pouch products |
US20170020183A1 (en) | 2014-04-04 | 2017-01-26 | X-International Aps | Tobacco Raw Material |
US9950858B2 (en) | 2015-01-16 | 2018-04-24 | R.J. Reynolds Tobacco Company | Tobacco-derived cellulose material and products formed thereof |
WO2018083114A1 (en) | 2016-11-02 | 2018-05-11 | Winnington Ab | Defibrated tobacco material |
US20190037909A1 (en) * | 2016-04-10 | 2019-02-07 | Vireo Health LLC | Cannabis Based Moist Snuff |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5941609B2 (en) * | 2006-08-01 | 2016-06-29 | アール・ジェイ・レノルズ・タバコ・カンパニーR.J.Reynolds Tobacco Company | Smokeless tobacco |
US8616221B2 (en) * | 2007-02-28 | 2013-12-31 | Philip Morris Usa Inc. | Oral pouch product with flavored wrapper |
US9010336B2 (en) * | 2009-10-09 | 2015-04-21 | Philip Morris Usa Inc. | Coil packaging for smokeless tobacco |
US9521864B2 (en) * | 2013-07-19 | 2016-12-20 | Altria Client Services Llc | Methods and systems for incorporating nicotine into oral products |
US20180271139A1 (en) * | 2017-03-22 | 2018-09-27 | Swedish Match North Europe Ab | Oral pouched product having a rectangular shape |
-
2019
- 2019-10-31 MX MX2022005285A patent/MX2022005285A/en unknown
- 2019-10-31 WO PCT/US2019/059090 patent/WO2021086367A1/en active IP Right Grant
- 2019-10-31 EP EP19805860.4A patent/EP4051020B1/en active Active
- 2019-10-31 CA CA3156573A patent/CA3156573A1/en active Pending
- 2019-10-31 JP JP2022525354A patent/JP7702942B2/en active Active
Patent Citations (178)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US787611A (en) | 1903-06-17 | 1905-04-18 | American Cigar Company | Treating tobacco. |
US1086306A (en) | 1912-11-11 | 1914-02-03 | Theodor Oelenheinz | Process of bleaching tobacco-leaves. |
US1376586A (en) | 1918-04-06 | 1921-05-03 | Schwartz Francis | Tobacco-tablet |
US1437095A (en) | 1920-06-01 | 1922-11-28 | August Wasmuth | Process of bleaching tobacco |
US1757477A (en) | 1927-07-11 | 1930-05-06 | Rosenhoch Samuel | Process and device for ozonizing tobacco |
US2148147A (en) | 1933-12-30 | 1939-02-21 | Degussa | Process for bleaching tobacco |
US2033909A (en) | 1934-12-19 | 1936-03-17 | Niacet Chemicals Corp | Manufacture of calcium levulinate |
US2170107A (en) | 1935-01-28 | 1939-08-22 | Degussa | Process for bleaching tobacco |
US2274649A (en) | 1935-01-28 | 1942-03-03 | Degussa | Process for bleaching tobacco |
US2122421A (en) | 1937-07-30 | 1938-07-05 | Du Pont | Tobacco treatment |
US2770239A (en) | 1952-02-04 | 1956-11-13 | Prats Jose Romero | Process of treating tobacco |
US3612065A (en) | 1970-03-09 | 1971-10-12 | Creative Enterprises Inc | Method of puffing tobacco and reducing nicotine content thereof |
US3901248A (en) | 1970-07-22 | 1975-08-26 | Leo Ab | Chewable smoking substitute composition |
US3943945A (en) | 1971-09-20 | 1976-03-16 | Rosen Enterprises, Inc. | Process for preparation of reconstituted tobacco sheet |
US3889689A (en) | 1971-12-20 | 1975-06-17 | Rosen Enterprise Inc | Method of treating tobacco with catalase and hydrogen peroxide |
US3851653A (en) | 1972-10-11 | 1974-12-03 | Rosen Enterprises Inc | Method of puffing tobacco and reducing nicotine content thereof |
US4340073A (en) | 1974-02-12 | 1982-07-20 | Philip Morris, Incorporated | Expanding tobacco |
US4144895A (en) | 1974-03-08 | 1979-03-20 | Amf Incorporated | Solvent extraction process |
US3943940A (en) | 1974-09-13 | 1976-03-16 | Isao Minami | Method of removing nicotine in smoking and a smoking filter to be used therefor |
US4143666A (en) | 1975-08-15 | 1979-03-13 | Philip Morris Incorporated | Smoking material |
US4148325A (en) | 1975-08-18 | 1979-04-10 | British-American Tobacco Company Limited | Treatment of tobacco |
US4194514A (en) | 1976-09-27 | 1980-03-25 | Stauffer Chemical Company | Removal of radioactive lead and polonium from tobacco |
US4150677A (en) | 1977-01-24 | 1979-04-24 | Philip Morris Incorporated | Treatment of tobacco |
US4267847A (en) | 1978-05-12 | 1981-05-19 | British-American Tobacco Company Limited | Tobacco additives |
US4289147A (en) | 1979-11-15 | 1981-09-15 | Leaf Proteins, Inc. | Process for obtaining deproteinized tobacco freed of nicotine and green pigment, for use as a smoking product |
US4589428A (en) | 1980-02-21 | 1986-05-20 | Philip Morris Incorporated | Tobacco treatment |
US4351346A (en) | 1980-03-08 | 1982-09-28 | B.A.T. Cigaretten-Fabriken Gmbh | Process for the preparation of aromatic substances |
US4359059A (en) | 1980-03-08 | 1982-11-16 | B.A.T. Cigaretten-Fabriken Gmbh | Process for the preparation of aromatic substances |
US4366824A (en) | 1981-06-25 | 1983-01-04 | Philip Morris Incorporated | Process for expanding tobacco |
US4366823A (en) | 1981-06-25 | 1983-01-04 | Philip Morris, Incorporated | Process for expanding tobacco |
US4388933A (en) | 1981-06-25 | 1983-06-21 | Philip Morris, Inc. | Tobacco stem treatment and expanded tobacco product |
US4506682A (en) | 1981-12-07 | 1985-03-26 | Mueller Adam | Clear tobacco aroma oil, a process for obtaining it from a tobacco extract, and its use |
US4725440A (en) | 1982-07-02 | 1988-02-16 | E. R. Squibb & Sons, Inc. | Antifungal pastille formulation and method |
US4660577A (en) | 1982-08-20 | 1987-04-28 | R.J. Reynolds Tobacco Company | Dry pre-mix for moist snuff |
US4528993A (en) | 1982-08-20 | 1985-07-16 | R. J. Reynolds Tobacco Company | Process for producing moist snuff |
US4513756A (en) | 1983-04-28 | 1985-04-30 | The Pinkerton Tobacco Company | Process of making tobacco pellets |
US4605016A (en) | 1983-07-21 | 1986-08-12 | Japan Tobacco, Inc. | Process for preparing tobacco flavoring formulations |
US4641667A (en) | 1983-12-09 | 1987-02-10 | B.A.T. Cigarettenfabriken Gmbh | Process of preparing nicotine N'-oxide and smoking products containing it |
US5092352A (en) | 1983-12-14 | 1992-03-03 | American Brands, Inc. | Chewing tobacco product |
US4624269A (en) | 1984-09-17 | 1986-11-25 | The Pinkerton Tobacco Company | Chewable tobacco based product |
US4716911A (en) | 1986-04-08 | 1988-01-05 | Genencor, Inc. | Method for protein removal from tobacco |
US4727889A (en) | 1986-12-22 | 1988-03-01 | R. J. Reynolds Tobacco Company | Tobacco processing |
US5018540A (en) | 1986-12-29 | 1991-05-28 | Philip Morris Incorporated | Process for removal of basic materials |
US5005593A (en) | 1988-01-27 | 1991-04-09 | R. J. Reynolds Tobacco Company | Process for providing tobacco extracts |
US5435325A (en) | 1988-04-21 | 1995-07-25 | R. J. Reynolds Tobacco Company | Process for providing tobacco extracts using a solvent in a supercritical state |
US4887618A (en) | 1988-05-19 | 1989-12-19 | R. J. Reynolds Tobacco Company | Tobacco processing |
US4987907A (en) | 1988-06-29 | 1991-01-29 | Helme Tobacco Company | Chewing tobacco composition and process for producing same |
US4967771A (en) | 1988-12-07 | 1990-11-06 | R. J. Reynolds Tobacco Company | Process for extracting tobacco |
US4986286A (en) | 1989-05-02 | 1991-01-22 | R. J. Reynolds Tobacco Company | Tobacco treatment process |
US4941484A (en) | 1989-05-30 | 1990-07-17 | R. J. Reynolds Tobacco Company | Tobacco processing |
US5060669A (en) | 1989-12-18 | 1991-10-29 | R. J. Reynolds Tobacco Company | Tobacco treatment process |
US5121757A (en) | 1989-12-18 | 1992-06-16 | R. J. Reynolds Tobacco Company | Tobacco treatment process |
US4991599A (en) | 1989-12-20 | 1991-02-12 | Tibbetts Hubert M | Fiberless tobacco product for smoking and chewing |
US5167244A (en) | 1990-01-19 | 1992-12-01 | Kjerstad Randy E | Tobacco substitute |
US5234008A (en) | 1990-02-23 | 1993-08-10 | R. J. Reynolds Tobacco Company | Tobacco processing |
US5065775A (en) | 1990-02-23 | 1991-11-19 | R. J. Reynolds Tobacco Company | Tobacco processing |
US5131414A (en) | 1990-02-23 | 1992-07-21 | R. J. Reynolds Tobacco Company | Tobacco processing |
US5099862A (en) | 1990-04-05 | 1992-03-31 | R. J. Reynolds Tobacco Company | Tobacco extraction process |
US5074319A (en) | 1990-04-19 | 1991-12-24 | R. J. Reynolds Tobacco Company | Tobacco extraction process |
US5668295A (en) | 1990-11-14 | 1997-09-16 | Philip Morris Incorporated | Protein involved in nicotine synthesis, DNA encoding, and use of sense and antisense DNAs corresponding thereto to affect nicotine content in transgenic tobacco cells and plants |
US5131415A (en) | 1991-04-04 | 1992-07-21 | R. J. Reynolds Tobacco Company | Tobacco extraction process |
US5318050A (en) | 1991-06-04 | 1994-06-07 | R. J. Reynolds Tobacco Company | Tobacco treatment process |
US5197494A (en) | 1991-06-04 | 1993-03-30 | R.J. Reynolds Tobacco Company | Tobacco extraction process |
US5343879A (en) | 1991-06-21 | 1994-09-06 | R. J. Reynolds Tobacco Company | Tobacco treatment process |
US5360022A (en) | 1991-07-22 | 1994-11-01 | R. J. Reynolds Tobacco Company | Tobacco processing |
US5148819A (en) | 1991-08-15 | 1992-09-22 | R. J. Reynolds Tobacco Company | Process for extracting tobacco |
US5243999A (en) | 1991-09-03 | 1993-09-14 | R. J. Reynolds Tobacco Company | Tobacco processing |
US5230354A (en) | 1991-09-03 | 1993-07-27 | R. J. Reynolds Tobacco Company | Tobacco processing |
US5301694A (en) | 1991-11-12 | 1994-04-12 | Philip Morris Incorporated | Process for isolating plant extract fractions |
US5259403A (en) | 1992-03-18 | 1993-11-09 | R. J. Reynolds Tobacco Company | Process and apparatus for expanding tobacco cut filler |
US5445169A (en) | 1992-08-17 | 1995-08-29 | R. J. Reynolds Tobacco Company | Process for providing a tobacco extract |
US5387416A (en) | 1993-07-23 | 1995-02-07 | R. J. Reynolds Tobacco Company | Tobacco composition |
US6077524A (en) | 1994-05-06 | 2000-06-20 | Bolder Arzneimittel Gmbh | Gastric acid binding chewing pastilles |
US5539093A (en) | 1994-06-16 | 1996-07-23 | Fitzmaurice; Wayne P. | DNA sequences encoding enzymes useful in carotenoid biosynthesis |
US5844119A (en) | 1994-12-21 | 1998-12-01 | The Salk Institute For Biological Studies | Genetically modified plants having modulated flower development |
WO1996031255A1 (en) | 1995-04-07 | 1996-10-10 | George Giolvas | Method and apparatus for the removal of harmful constituents from cigarettes and tobacco before smoking |
US5705624A (en) | 1995-12-27 | 1998-01-06 | Fitzmaurice; Wayne Paul | DNA sequences encoding enzymes useful in phytoene biosynthesis |
US5713376A (en) | 1996-05-13 | 1998-02-03 | Berger; Carl | Non-addictive tobacco products |
US5908032A (en) | 1996-08-09 | 1999-06-01 | R.J. Reynolds Tobacco Company | Method of and apparatus for expanding tobacco |
US6298859B1 (en) | 1998-07-08 | 2001-10-09 | Novozymes A/S | Use of a phenol oxidizing enzyme in the treatment of tobacco |
US6923981B2 (en) | 1998-09-25 | 2005-08-02 | Warner-Lambert Company | Fast dissolving orally consumable films |
US6131584A (en) | 1999-04-15 | 2000-10-17 | Brown & Williamson Tobacco Corporation | Tobacco treatment process |
US6895974B2 (en) | 1999-04-26 | 2005-05-24 | R. J. Reynolds Tobacco Company | Tobacco processing |
US6887307B1 (en) | 1999-07-22 | 2005-05-03 | Warner-Lambert Company, Llc | Pullulan film compositions |
US6510855B1 (en) | 2000-03-03 | 2003-01-28 | Brown & Williamson Tobacco Corporation | Tobacco recovery system |
US20060236434A1 (en) | 2000-08-30 | 2006-10-19 | North Carolina State University | Methods and compositions for tobacco plants with reduced nicotine |
US7230160B2 (en) | 2001-03-08 | 2007-06-12 | Michigan State University | Lipid metabolism regulators in plants |
US6834654B2 (en) | 2001-05-01 | 2004-12-28 | Regent Court Technologies, Llc | Smokeless tobacco product |
US6668839B2 (en) | 2001-05-01 | 2003-12-30 | Jonnie R. Williams | Smokeless tobacco product |
US20040020503A1 (en) | 2001-05-01 | 2004-02-05 | Williams Jonnie R. | Smokeless tobacco product |
US7208659B2 (en) | 2001-05-02 | 2007-04-24 | Conopco Inc. | Process for increasing the flavonoid content of a plant and plants obtainable thereby |
US7173170B2 (en) | 2001-09-10 | 2007-02-06 | Reynolds Technologies, Inc. | High threonine producing lines of Nicotiana tobacum and methods of producing |
US6730832B1 (en) | 2001-09-10 | 2004-05-04 | Luis Mayan Dominguez | High threonine producing lines of Nicotiana tobacum and methods for producing |
US6953040B2 (en) | 2001-09-28 | 2005-10-11 | U.S. Smokeless Tobacco Company | Tobacco mint plant material product |
US7032601B2 (en) | 2001-09-28 | 2006-04-25 | U.S. Smokeless Tobacco Company | Encapsulated materials |
US6772767B2 (en) | 2002-09-09 | 2004-08-10 | Brown & Williamson Tobacco Corporation | Process for reducing nitrogen containing compounds and lignin in tobacco |
US7025066B2 (en) | 2002-10-31 | 2006-04-11 | Jerry Wayne Lawson | Method of reducing the sucrose ester concentration of a tobacco mixture |
US20040191322A1 (en) | 2002-12-20 | 2004-09-30 | Henri Hansson | Physically and chemically stable nicotine-containing particulate material |
US7556047B2 (en) | 2003-03-20 | 2009-07-07 | R.J. Reynolds Tobacco Company | Method of expanding tobacco using steam |
WO2004095959A1 (en) | 2003-04-29 | 2004-11-11 | Swedish Match North Europe Ab | Oral snuff product and method for producing the same |
US7014039B2 (en) | 2003-06-19 | 2006-03-21 | R.J. Reynolds Tobacco Company | Sliding shell package for smoking articles |
US20090014450A1 (en) | 2003-08-18 | 2009-01-15 | Gustavus Ab | Snuff-box lid |
US20050115580A1 (en) | 2003-11-03 | 2005-06-02 | Quinter Phillip F. | Flavored smokeless tobacco and methods of making |
WO2005041699A2 (en) | 2003-11-03 | 2005-05-12 | U.S. Smokeless Tobacco Company | Flavored smokeless tabacco and methods of making |
US20050244521A1 (en) | 2003-11-07 | 2005-11-03 | Strickland James A | Tobacco compositions |
US20060191548A1 (en) | 2003-11-07 | 2006-08-31 | Strickland James A | Tobacco compositions |
WO2005063060A1 (en) | 2003-12-22 | 2005-07-14 | U.S. Smokeless Tobacco Company | Conditioning process for tobacco and/or snuff compositions |
US7694686B2 (en) | 2003-12-22 | 2010-04-13 | U.S. Smokeless Tobacco Company | Conditioning process for tobacco and/or snuff compositions |
US20080196730A1 (en) | 2004-07-02 | 2008-08-21 | Radi Medical Systems Ab | Smokeless Tobacco Product |
US7337782B2 (en) | 2004-08-18 | 2008-03-04 | R.J. Reynolds Tobacco Company | Process to remove protein and other biomolecules from tobacco extract or slurry |
US7798153B2 (en) | 2004-08-23 | 2010-09-21 | Us Smokeless Tobacco Co. | Nicotiana Kawakamii smokeless tobacco |
US7650892B1 (en) | 2004-09-03 | 2010-01-26 | Rosswil Llc Ltd. | Methods for hindering formation of tobacco-specific nitrosamines |
US7537110B2 (en) | 2005-06-02 | 2009-05-26 | Philip Morris Usa Inc. | Container for consumer article |
US7584843B2 (en) | 2005-07-18 | 2009-09-08 | Philip Morris Usa Inc. | Pocket-size hand-held container for consumer items |
US20070062549A1 (en) | 2005-09-22 | 2007-03-22 | Holton Darrell E Jr | Smokeless tobacco composition |
US20070186942A1 (en) | 2006-01-31 | 2007-08-16 | U. S. Smokeless Tobacco Company | Tobacco Articles and Methods |
US20080029110A1 (en) | 2006-02-10 | 2008-02-07 | R. J. Reynolds Tobacco Company | Smokeless Tobacco Composition |
US7861728B2 (en) | 2006-02-10 | 2011-01-04 | R.J. Reynolds Tobacco Company | Smokeless tobacco composition having an outer and inner pouch |
US20070186941A1 (en) | 2006-02-10 | 2007-08-16 | Holton Darrell E Jr | Smokeless tobacco composition |
US20090065013A1 (en) | 2006-04-28 | 2009-03-12 | Swedish Match North Europe Ab | moist snuff non-tobacco composition and a method for producing thereof |
US8642016B2 (en) * | 2006-07-21 | 2014-02-04 | Jsrnti, Llc | Medicinal delivery system, and related methods |
US20080173317A1 (en) | 2006-08-01 | 2008-07-24 | John Howard Robinson | Smokeless tobacco |
US20080029116A1 (en) | 2006-08-01 | 2008-02-07 | John Howard Robinson | Smokeless tobacco |
US20100084424A1 (en) | 2006-12-12 | 2010-04-08 | John Gelardi | Container with pivoting cover |
US20080209586A1 (en) | 2007-02-23 | 2008-08-28 | U.S. Smokeless Tobacco Company | Novel tobacco compositions and methods of making |
WO2008103935A2 (en) | 2007-02-23 | 2008-08-28 | U.S. Smokeless Tobacco Company | Novel tobacco compositions and methods of making |
US8186360B2 (en) | 2007-04-04 | 2012-05-29 | R.J. Reynolds Tobacco Company | Cigarette comprising dark air-cured tobacco |
US20090014343A1 (en) | 2007-05-07 | 2009-01-15 | Philip Morris Usa Inc. | Pocket-size hybrid container for consumer items |
US20080305216A1 (en) | 2007-06-08 | 2008-12-11 | Philip Morris Usa Inc. | Capsule clusters for oral consumption |
US20090025738A1 (en) | 2007-07-23 | 2009-01-29 | R. J. Reynolds Tobacco Company | Smokeless Tobacco Composition |
US8061362B2 (en) | 2007-07-23 | 2011-11-22 | R. J. Reynolds Tobacco Company | Smokeless tobacco composition |
US9237769B2 (en) | 2007-07-23 | 2016-01-19 | R. J. Reynolds Tobacco Company | Smokeless tobacco composition |
USD594154S1 (en) | 2007-11-13 | 2009-06-09 | R.J. Reynolds Tobacco Company | Container with bottom compartment |
US20090293889A1 (en) | 2007-11-28 | 2009-12-03 | Philip Morris Usa Inc. | Smokeless compressed tobacco product for oral consumption |
US20090250360A1 (en) | 2007-11-30 | 2009-10-08 | Philip Morris Usa Inc. | Pocket-size container for consumer items |
USD592956S1 (en) | 2008-02-08 | 2009-05-26 | Philip Morris Usa Inc. | Container |
US20090230003A1 (en) | 2008-02-08 | 2009-09-17 | Philip Morris Usa Inc. | Pocket-sized container |
US20090223989A1 (en) | 2008-03-04 | 2009-09-10 | R.J. Reynolds Tobacco Company | Dispensing Container |
US20090266837A1 (en) | 2008-04-25 | 2009-10-29 | R. J. Reynolds Tobacco Company | Dispensing Container |
US20100133140A1 (en) | 2008-12-01 | 2010-06-03 | Bailey Ryan A | Dual cavity sliding dispenser |
US20100291245A1 (en) | 2008-12-08 | 2010-11-18 | Philip Morris Usa Inc. | Soft, chewable and orally dissolvable and/or disintegrable products |
US20120067361A1 (en) | 2009-04-03 | 2012-03-22 | X-International Aps | Plant fiber product and method for its manufacture |
US20100264157A1 (en) | 2009-04-16 | 2010-10-21 | R.J. Reynolds Tobacco Company | Dispensing container for metered dispensing of product |
USD625178S1 (en) | 2009-04-16 | 2010-10-12 | R.J. Reynolds Tobacco Company, Inc. | Container with hinged insert |
WO2010132444A2 (en) | 2009-05-11 | 2010-11-18 | U.S. Smokeless Tobacco Company Llc | Method and device for flavoring smokeless tobacco |
US20100282267A1 (en) | 2009-05-11 | 2010-11-11 | Frank Atchley | Method and device for flavoring smokeless tobacco |
US8434496B2 (en) | 2009-06-02 | 2013-05-07 | R. J. Reynolds Tobacco Company | Thermal treatment process for tobacco materials |
US8944072B2 (en) | 2009-06-02 | 2015-02-03 | R.J. Reynolds Tobacco Company | Thermal treatment process for tobacco materials |
US8991403B2 (en) | 2009-06-02 | 2015-03-31 | R.J. Reynolds Tobacco Company | Thermal treatment process for tobacco materials |
US20110139164A1 (en) | 2009-12-15 | 2011-06-16 | R. J. Reynolds Tobacco Company | Tobacco Product And Method For Manufacture |
US20110168712A1 (en) | 2010-01-12 | 2011-07-14 | R.J. Reynolds Tobacco Company | Dispensing container |
US8397945B2 (en) | 2010-02-23 | 2013-03-19 | R.J. Reynolds Tobacco Company | Dispensing container |
US20110247640A1 (en) | 2010-04-08 | 2011-10-13 | R. J. Reynolds Tobacco Company | Smokeless Tobacco Composition Comprising Tobacco-Derived Material and Non-Tobacco Plant Material |
US20120037175A1 (en) | 2010-08-11 | 2012-02-16 | R.J. Reynolds Tobacco Company | Meltable smokeless tobacco composition |
US20120055494A1 (en) | 2010-09-07 | 2012-03-08 | Rj Reynolds Tobacco Company | Smokeless Tobacco Product Comprising Effervescent Composition |
US8931493B2 (en) | 2010-11-01 | 2015-01-13 | R.J. Reynolds Tobacco Co. | Smokeless tobacco products |
US20120138073A1 (en) | 2010-12-01 | 2012-06-07 | Rj Reynolds Tobacco Company | Smokeless tobacco pastille and injection molding process for forming smokeless tobacco products |
US20120138074A1 (en) | 2010-12-01 | 2012-06-07 | Rj Reynolds Tobacco Company | Smokeless tobacco pastille and moulding process for forming smokeless tobacco products |
US20130074855A1 (en) | 2011-09-22 | 2013-03-28 | R.J. Reynolds Tobacco Company | Translucent smokeless tobacco product |
US20130074856A1 (en) | 2011-09-22 | 2013-03-28 | R.J. Reynolds Tobacco Company | Translucent smokeless tobacco product |
US20130152953A1 (en) | 2011-12-14 | 2013-06-20 | R. J. Reynolds Tobacco Company | Smokeless tobacco product comprising effervescent composition |
US9420825B2 (en) | 2012-02-13 | 2016-08-23 | R.J. Reynolds Tobacco Company | Whitened tobacco composition |
US20130206153A1 (en) * | 2012-02-13 | 2013-08-15 | R.J. Reynolds Tobacco Company | Whitened tobacco composition |
US20130274296A1 (en) | 2012-04-17 | 2013-10-17 | R.J. Reynolds Tobacco Company | Remelted ingestible products |
US9339058B2 (en) | 2012-04-19 | 2016-05-17 | R. J. Reynolds Tobacco Company | Method for producing microcrystalline cellulose from tobacco and related tobacco product |
US20150068545A1 (en) | 2013-09-09 | 2015-03-12 | R.J. Reynolds Tobacco Company | Smokeless tobacco composition incorporating a botanical material |
US20150101627A1 (en) | 2013-10-16 | 2015-04-16 | R.J. Reynolds Tobacco Company | Smokeless tobacco pastille |
US20150230515A1 (en) | 2014-02-14 | 2015-08-20 | R.J. Reynolds Tobacco Company | Tobacco-containing gel composition |
US20170112183A1 (en) | 2014-04-04 | 2017-04-27 | X-International Aps | Tobacco Raw Material |
US20170020183A1 (en) | 2014-04-04 | 2017-01-26 | X-International Aps | Tobacco Raw Material |
US20160000140A1 (en) | 2014-07-02 | 2016-01-07 | R.J. Reynolds Tobacco Company | Oral pouch products |
US20160073686A1 (en) | 2014-09-12 | 2016-03-17 | R.J. Reynolds Tobacco Company | Tobacco-derived filter element |
US20160073689A1 (en) | 2014-09-12 | 2016-03-17 | R.J. Reynolds Tobacco Company | Nonwoven pouch comprising heat sealable binder fiber |
US20160157515A1 (en) | 2014-12-05 | 2016-06-09 | R.J. Reynolds Tobacco Company | Smokeless tobacco pouch |
US20160192703A1 (en) | 2015-01-07 | 2016-07-07 | R.J. Reynolds Tobacco Company | Oral pouch products |
US9950858B2 (en) | 2015-01-16 | 2018-04-24 | R.J. Reynolds Tobacco Company | Tobacco-derived cellulose material and products formed thereof |
US20190037909A1 (en) * | 2016-04-10 | 2019-02-07 | Vireo Health LLC | Cannabis Based Moist Snuff |
WO2018083114A1 (en) | 2016-11-02 | 2018-05-11 | Winnington Ab | Defibrated tobacco material |
Non-Patent Citations (7)
Title |
---|
"Tobacco Production, Chemistry and Technology", 1999 |
GOODSPEED, THE GENUS NICOTIANA, (CHONICA BOTANICA, 1954 |
LEFFINGWELL ET AL.: "Tobacco Flavoring for Smoking Products", 1972, R. J. REYNOLDS TOBACCO COMPANY |
NESTOR ET AL., BEITRAGE TABAKFORSCH. INT., vol. 20, 2003, pages 467 - 475 |
PERFETTI, BEITRAGE TABAKFORSCHUNGINT., vol. 12, 1983, pages 43 - 54 |
STAAF ET AL., BEITRAGE TABAKFORSCH. INT., vol. 21, 2005, pages 321 - 330 |
THE EFSA JOURNAL, vol. 85, 2004, pages 1 - 32 |
Cited By (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3809884B1 (en) | 2019-06-07 | 2022-09-21 | Philip Morris Products S.A. | Nicotine pouch product |
EP4072332B1 (en) | 2019-12-09 | 2024-12-11 | Nicoventures Trading Limited | Moist oral compositions |
US12064424B2 (en) | 2019-12-09 | 2024-08-20 | Nicoventures Trading Limited | Moist oral compositions |
US11793230B2 (en) | 2019-12-09 | 2023-10-24 | Nicoventures Trading Limited | Oral products with improved binding of active ingredients |
US11826462B2 (en) | 2019-12-09 | 2023-11-28 | Nicoventures Trading Limited | Oral product with sustained flavor release |
US11872231B2 (en) | 2019-12-09 | 2024-01-16 | Nicoventures Trading Limited | Moist oral product comprising an active ingredient |
US11969502B2 (en) | 2019-12-09 | 2024-04-30 | Nicoventures Trading Limited | Oral products |
US12310959B2 (en) | 2019-12-09 | 2025-05-27 | Nicoventures Trading Limited | Oral compositions with reduced water content |
US20210169889A1 (en) * | 2019-12-09 | 2021-06-10 | Nicoventures Trading Limited | Oral products |
EP4072330B1 (en) | 2019-12-09 | 2024-12-11 | Nicoventures Trading Limited | Oral products with reduced irritation |
US11712059B2 (en) * | 2020-02-24 | 2023-08-01 | Nicoventures Trading Limited | Beaded tobacco material and related method of manufacture |
US20210259299A1 (en) * | 2020-02-24 | 2021-08-26 | Nicoventures Trading Limited | Beaded Tobacco Material and Related Method of Manufacture |
US12382982B2 (en) | 2021-06-25 | 2025-08-12 | Nicoventures Trading Limited | Oral products and method of manufacture |
WO2023281469A1 (en) * | 2021-07-09 | 2023-01-12 | Nicoventures Trading Limited | Extruded structures |
DK181787B1 (en) * | 2022-01-28 | 2025-01-03 | Mac Baren Tobacco Company As | Bag composition comprising one or more water-insoluble fibers |
US12295412B2 (en) | 2022-01-28 | 2025-05-13 | Altria Client Services Llc | Oral pouch product |
DK181550B1 (en) * | 2022-01-28 | 2024-05-02 | Mac Baren Tobacco Company As | Method for producing a pouch composition |
WO2024160334A1 (en) * | 2023-02-03 | 2024-08-08 | Fertin Pharma A/S | A nicotine pouch composition |
Also Published As
Publication number | Publication date |
---|---|
MX2022005285A (en) | 2022-05-24 |
JP7702942B2 (en) | 2025-07-04 |
EP4051020B1 (en) | 2025-08-06 |
JP2023506123A (en) | 2023-02-15 |
EP4051020A1 (en) | 2022-09-07 |
CA3156573A1 (en) | 2021-05-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US12064424B2 (en) | Moist oral compositions | |
EP4051020B1 (en) | Oral product and method of manufacture | |
US11889856B2 (en) | Oral foam composition | |
US20210169132A1 (en) | Oral composition including gels | |
US20250287988A1 (en) | Oral product with cellulosic flavor stabilizer | |
US12213510B2 (en) | Pouched products with enhanced flavor stability | |
US20230270863A1 (en) | Oral products with reduced irritation | |
US20210169123A1 (en) | Pouched products with enhanced flavor stability | |
US20210169890A1 (en) | Oral composition with polymeric component | |
US20250152573A1 (en) | Oral compositions with reduced water content | |
US20250241357A1 (en) | Methods of manufacturing an oral composition | |
US11826462B2 (en) | Oral product with sustained flavor release | |
US20210169126A1 (en) | Oral composition with salt inclusion | |
US12151023B2 (en) | Oral composition with beet material | |
US20210169783A1 (en) | Oral products with controlled release | |
US20210169784A1 (en) | Buffered oral compositions | |
US20210169785A1 (en) | Oral compositions with reduced water activity | |
US20210169129A1 (en) | Lipid-containing oral composition | |
RU2828658C1 (en) | Product for oral use and method of its preparation | |
US11793230B2 (en) | Oral products with improved binding of active ingredients | |
WO2021116916A1 (en) | Oral product with multiple flavors having different release profiles |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 19805860 Country of ref document: EP Kind code of ref document: A1 |
|
ENP | Entry into the national phase |
Ref document number: 2022525354 Country of ref document: JP Kind code of ref document: A Ref document number: 3156573 Country of ref document: CA |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
ENP | Entry into the national phase |
Ref document number: 2019805860 Country of ref document: EP Effective date: 20220531 |
|
WWG | Wipo information: grant in national office |
Ref document number: 2019805860 Country of ref document: EP |